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ABSTRACT
This study tested the hypotheses that peripheral forearm but not central vascular 
mechanics are modified in young smokers but can be restored following a 14 week of 
intervention program of aerobic exercise and smoking cessation. Central and Peripheral 
vascular mechanics were compared in smokers pre (n=53) and post intervention (n=22) 
and age-matched non-smokers (n=25) (18-40 yrs). Measures included carotid to finger 
and toe pulse wave velocity, carotid and brachial arteries, and forearm vascular bed 
mechanics, to segment central and peripheral regions. Central vascular mechanics were 
not different between non-smokers and smokers. Compared to non-smokers, R, K, and L 
were greater and C was decreased in smokers (p<0.05). Relative to smoking baseline, R 
and L were reduced, C was increased (p<0.05), and K was unchanged following the 
intervention. In young smokers, in the absence of central changes smoking induced 
alterations in the periphery were reversible following an intervention program.
Keywords: Pulse wave velocity, Arterial Stiffness, Peripheral Vascular Mechanics, 
Cigarette Smoking, Vascular Disease
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Vascular disease, a disease affecting the arterial vasculature, is a leading cause of 
death among Canadians (153). Early detection of vascular disease would significantly 
impact intervention strategies and the promotion of healthy living. Although many 
clinical and research risk factors have been heavily investigated and identified, even 
earlier detection may improve intervention programs and the understanding of the 
progression of this disease.
The clinical determination of vascular disease relies heavily on measures of central 
artery vascular mechanics. Common detection analyses study the large conduit vessels 
and quantify markers of disease such as intima media thickness (IMT), local compliance 
and distensibility, pulse pressure (PP), augmentation index, and pulse wave velocity 
(PWV). Although these measurements are correlated to the likelihood of developing 
vascular disease, a major limitation of these parameters is that they investigate mechanics 
of large, central arteries only. Recent, evidence suggests that downstream changes in the 
small, peripheral resistance arterioles may precede these central changes (93). Therefore, 
simply investigating markers of central vascular stiffness does not adequately describe the 
arterial system (210).
The vascular properties that regulate blood pressure (BP) and blood flow are 
important to study as in disease states, these parameters are altered and may provide 
evidence for the progression of vascular disease. These BP and flow waveforms travel 
throughout the arterial vasculature in the large, central conduit arteries through the many 
branches to the small, peripheral resistance arterioles (137). The central and peripheral
CHAPTER 1 : INTRODUCTION
arteries of the cardiovascular system play an important role in the conduction of blood 
flow to the periphery. The elastic properties of these vessels allow for the smoothing of 
oscillations in BP, reduction of the PP, and perfusion of the organs. These properties are 
dependent on the composition and geometry of the walls of the arteries, which determine 
the velocity of the propagation of the forward and backward (reflected) travelling 
pressure waves and resulting blood flow. Forward pressure waves generated from the 
heart can be reflected at branching points, areas of alteration in arterial geometry, or 
terminal arterioles and this reflected pressure waveform can alter blood flow in the central 
arteries. Kember and colleagues (2004) demonstrated that this dynamic pattern of central 
PP is determined by downstream conditions, or information from the periphery, as global 
information is required for adequate cardiovascular control (93). In a stiffer, peripheral 
vascular bed, the reflected pressure waveform will travel faster backup towards the heart. 
This increased velocity of the reflected waveform will reach the heart earlier in systole, 
causing a higher systolic pressure. In cases of aging or diseased vessels, the constant 
attenuation in BP may lead to vascular remodelling. Thus, through pressure distribution, 
the affect of peripheral alterations on the control of BP regulation can affect central 
arteries (93; 109). Therefore, the properties regulating BP and blood flow in peripheral 
arteries may serve as an early marker of disease.
The properties regulating BP and delivery of blood flow are determined by many 
parameters throughout the vasculature that contribute to the steady, continuous flow, and 
the pulsatile, oscillatory dynamics of blood flow (178). Resistance is the pressure that the 
heart must overcome to deliver adequate blood to the periphery. Resistance equals mean 
arterial pressure (MAP) divided by cardiac output (Q), the amount of blood ejected per
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minute from the heart (137). While it was previously believed that resistance was the only 
parameter regulating blood flow, this component only deals with the steady state. Blood 
flow is pulsatile and, therefore, during each cardiac cycle, other parameters of the vessel 
wall regulate both the pressure and flow waveforms (210). These other parameters have 
been identified as the compliance or elasticity of vessel wall, the viscoelasticity, or 
resistance to stretch of the vessel wall, and the inertia of the blood and tissues (210; 211). 
While the steady state components of blood flow have been studied extensively, the 
pulsatile components are not as well known. Additionally, these parameters vary 
throughout the vascular tree and these properties in the periphery are not well studied. 
Therefore central and peripheral dynamic vascular properties should be investigated to 
understand the entire arterial tree and vascular mechanics.
The inadequate understanding of peripheral vascular mechanics is due to the 
limitations of studying these small vessels in vivo. Recently our lab has developed a 
model to study the peripheral vascular bed using a mathematical Windkessel model (210; 
211). This model incorporates the resistance (R), compliance (C), viscoelasticity (K), and 
inertia (L) of the downstream vasculature. These parameters are regulated by both the 
passive and active properties of the blood vessel. The ability to detect changes in these 
parameters, namely R, C, K, and L in the peripheral vascular bed may help improve 
detection of vascular disease.
In this study, smoking was used as a model for vascular disease. Smoking, the number 
one preventable risk factor for vascular disease (188), is an ideal model to study the 
central and peripheral alterations that may occur in a disease state. While smoking has 
been shown to have profound effects on central, steady state, vascular mechanics, the
parameters affecting blood flow in the periphery remained to be investigated. Young 
individuals, without vascular disease, represent a sample population to study to 
investigate these early changes, without the confounding factors of aging. Separating the 
arterial tree into central and peripheral vascular mechanics may allude to vascular 
alterations and progression in disease states.
1.2 Purpose
The purpose of this study was to investigate central and peripheral arterial vascular 
mechanics in young smokers and non-smokers. The second purpose was to determine 
whether these altered vascular mechanics can be improved following a 14 week 
intervention program of aerobic exercise and smoking cessation program.
1.3 Hypothesis
It was hypothesized that vascular mechanics will be affected detrimentally in the 
peripheral vascular bed of young smokers in the absence of central changes. This 
hypothesis predicts that, compared to non-smoking control subjects, peripheral vascular 
mechanics will be altered in young smokers. Despite these changes in the periphery, it is 
hypothesized that central vascular measurements will not be different between non- 
smokers and smokers. The second hypothesis was that these altered peripheral vascular 




CHAPTER 2 : LITERATURE REVIEW
2.1 Introduction
To fully understand vascular mechanics and vascular disease, one must investigate the 
arterial vasculature. Therefore this literature review examines: 1) vascular tree anatomy, 
2) the components regulating BP and flow, 3) central and peripheral vascular mechanics, 
4) how we can measure and quantify central and peripheral vascular mechanics, 5) how 
vascular disease may alter these components, 6) how to quantify the impact of smoking 
on the segmental vascular tree mechanics, and 7) whether such changes can be reversed 
through lifestyle intervention.
2.2 Arterial Tree
The cardiovascular system in a human is designed to transport blood throughout the 
body, delivering oxygen and nutrients essential for living (137; 168). The circulation of 
blood consists of two circuits, the pulmonary and the systemic circuit (137). For this 
review, we will focus on the systemic circulation, and more specifically, the arterial side 
as it pertains to vascular mechanics.
The systemic circulation begins with the heart, which acts like a pump to distribute 
blood to all parts of the body. The circulation of blood flow from this pump was 
recognized by William Harvey in 1628 and was simplified into a model of blood leaving 
the left ventricle and returning to the right atrium (137; 163). This single loop model does 
not identify the arterial branching network that encompasses the systemic circulation and 
the physiological control of the circulation (12). The vascular system has the hierarchical 
form of a tree structure, as the arteries branch from the major root, the aorta, and travel 
along a branching system to terminal arterioles and thus the capillaries. It is in the
capillaries where vital nutrients and oxygen can be transmitted to organs and muscle 
(137). The capillaries also extract waste and veins carry the oxygen- depleted blood back 
to the heart and pulmonary circulation (137).
Once blood leaves the heart, the arteries receive the blood at a high pressure and 
velocity and conduct it throughout the body (137). Pressure waveforms are transmitted 
from the heart and reflected at terminal arterioles and at various obstacles, such as 
bifurcations, and, therefore, the arrangement of this branching network affects the 
propagation and reflection of waveforms (179). The branching networks of arteries 
function to cushion the high pressure generated from the heart and transform this flow to 
the periphery (140; 179). The first branches from the heart are large, conduit, elastic 
arteries containing substantial amounts of elastin that allow the vessels to inflate and 
recoil while transmitting pulsatile flow generated from the heart. These large vessels are 
not only elastic, but also contain large amounts of fibrous tissue to provide strength to 
cushion pressure (11; 16). The periphery, or small arteries and arterioles, act as control 
valves (16; 137). These arteries are often referred to as muscular arteries, as they are less 
compliant, but capable of active changes in vessel diameter (16).
The transition from arteries to arterioles is a gradual one and is associated with a 
progressive reduction in the calibre of the lumen and thickness of the vessel wall (168). 
The design of the vascular wall is also altered to account for the vessel’s function in 
regulating blood flow. The geometry and composition of the large (central) versus smaller 
(peripheral) arteries will be discussed further in Section 2.3. Although the components of 
the wall vary between large and small arteries, they all consist of three vital layers with
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different functions: 1) the tunica intima, the innermost layer; 2) the tunica media, the 
middle layer; 3) the tunica adventitia, the outermost layer.
2.2.1 Tunica Intima
The tunica intima, is the inner surface of the arterial vessel. The endothelium is the 
predominant component of the tunica intima. This layer is in contact with the blood and 
therefore interacts with the components of the blood and responds to the velocity and 
volume of blood flow (137; 168). The endothelium is uniquely positioned between the 
vascular smooth muscle and the blood and performs multiple functions in the physiology 
of circulation (140). It was previously believed that the only function of the endothelium 
was to act as a barrier between the blood and vessel, but the Nobel prize winning 
observation that acetylcholine-mediated relaxations were dependent on an intact 
endothelium provided evidence as to the considerable biological potential of the 
endothelium (60). Endothelium-derived relaxation factors (EDRFs) are released to cause 
vasorelaxation, and perform the pivotal role of the endothelium (196). The existence of an 
EDRF was postulated by Furchgott and Zawadski (1980) when the relaxant action of 
acetylcholine in pre-constricted rabbit aorta strips was abolished in strips with the 
endothelium removed. This loss of relaxation was quantitatively related to the histological 
measured loss of endothelial cells. Subsequently, it was discovered that one of the major 
EDRFs is nitric oxide, a biological agent that helps maintain arterial tone in the 
vasculature (79). Nitric oxide, which is mainly synthesized in the endothelial cells, is a 
signalling molecule that is produced from activation of the endothelium (140). 
Prostacyclin has been identified as another EDRF; however, its role in endothelial 
function and disease is not as well known as nitric oxide. The relaxation through cellular 
signalling increases the diameter of blood vessels, thus increasing flow and decreasing
7
pressure. The endothelial layer also performs other distinctive functions: it is involved in 
the regulation of coagulation, leukocyte adhesion in inflammation, vessel relaxation and 
constriction, and vascular smooth muscle growth (140).
Nitric oxide release results in vascular relaxation and inhibits leukocyte adhesion to 
the endothelium (56). Nitric oxide bioavailability is therefore essential for the 
maintenance of endothelial function and vasorelaxation. Various studies illustrate that 
alterations in the release of vasodilators synthesized by the vessel wall occur at an early 
stage in the atherosclerotic process (77; 99; 121; 134; 136). The vascular endothelium 
regulates arterial relaxation and contraction, controls platelet and leukocyte interactions, 
and controls vascular growth (137; 140; 169).
2.2.2 Tunica Media
The second or middle layer, is known as the tunica media and consists of smooth 
muscle cells and elastic fibres (168). In larger vessels, elastin fibres dominate the media 
layer while as the arteries become smaller, the number of smooth muscle fibres increase 
(179). Unlike endothelial cells which are arranged longitudinally along the vessel, smooth 
muscle cells are found in a circular pattern around the blood vessel, though some are 
oriented in parallel (50; 137; 168). The tight helical or circular arrangement of smooth 
muscle cells allow for control of vessel diameter by vasoconstriction or vasodilation 
(168). The diameter of the vessel controls the resistance, as a change in diameter will alter 
resistance and thus blood flow. Poiseuille’s Law states that resistance is inversely related 
to the radius to the fourth power (137). Therefore a small change in diameter will have a 
large impact on resistance.
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Morphological studies have compared the contractile components of smooth muscle 
cells to that of striated muscles (179). The contractile components of smooth muscle cells 
consist of actin and myosin and are regulated by intracellular calcium levels. Unlike the 
endothelial cell, which produces dilatory compounds in response to increased calcium 
levels, smooth muscle cells constrict with increasing calcium (167; 172). Two 
mechanisms can contribute to increased calcium concentrations inside smooth muscle 
cells. 1) Depolarization of the smooth muscle is followed by the opening of L-type 
voltage gated channels. This influx leads to further release of calcium from intracellular 
stores; and 2) Binding of a hormone to its receptor leads to an increase in intracellular 
calcium via receptor-operated calcium channels or G-protein coupled activation.
Increased calcium inside the cells allows actin-myosin interaction and the shortening of 
smooth muscle cells (27; 167).
Previously it was thought that smooth muscle contraction or dilation affected the 
diameter, or resistance of the vessel only. This is incomplete due to the pulsatile nature of 
blood flow as smooth muscle responses also affect arterial compliance or stiffness. 
Smooth muscle relaxation has been shown to alter the wall stiffness or elastic modulus 
(15). Smooth muscle can increase stiffness by contracting the collagen and elastin fibres 
in parallel with the smooth muscle (33; 165). However, it also decreases stiffness by 
reducing the tension in the smooth muscle itself and in the series elastic component. 
Therefore the net effect depends on the contribution of each of these components in the 
vessel wall.
Smooth muscle cells found in the tunica media provide a mechanism to regulate 
arterial mechanical properties (179). Smooth muscle cells are highly innervated by the
9
sympathetic nervous system, interact with the endothelium, and exhibit receptors for 
various regulatory molecules (53). A wide variety of stimuli activate the contractile 
properties of smooth muscle cells.
2.2.3 Tunica Adventia
The outermost layer, the tunica adventia, is composed of collagen and elastin fibres 
(168). Collagen is a connective tissue protein that gives the vessel strength and protects 
the arteries from the high pressure, pulsatile flow generated from the heart. The elastin 
enables the vessel to recoil to contribute to the propagation of pressure and flow 
throughout the circulation (37). The ratio of collagen to elastin is thought to be a major 
contributor to the compliance or distensibility of a vessel (55; 57).
Elastin fibres are found in both the tunica media and adventia layers. Elastin is a 
protein in connective tissue that coils and recoils similar to a spring and accounts for the 
elasticity of the vessel wall at low pressures (57). Elastin is important in arteries as it 
enables distensibility that, in turn, functions to propagate pressure waves and transmit 
blood flow throughout the systemic circulation. The basic structure of elastin enables 
arteries to function as a mechanism to buffer and store pulsatile flow as it is able to 
distribute forces throughout the wall (179). Within each cardiac cycle, elastin allows the 
vessel to expand to buffer the pressure increase, store the increased volume of flow, and 
transmit this volume to the various parts of the body.
Vessel walls are not purely elastic because collagen, a connective protein fibre, 
provides the tensile strength at higher pressures. Collagen is predominately found in the 
tunica adventia (168; 179). The collagen fibres are flexible, yet they have considerable 
strength. The fibres are usually arranged in parallel bundles and are recruited as
10
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transmural pressure increases to bear mechanical load (16). Collagen spreads the pulsatile 
load of the pulse wave and thus prevents overstretching of the elastic element (41). The 
structure of collagen is fundamentally different from that of elastin as it is composed of 
closely-wound helical chains which are tightly cross-linked, thereby restricting their 
distensibility. Comparing the elastic modulus, an engineering measure of stiffness, of 
collagen and elastin indicates that collagen is several hundred to one thousand times as 
stiff as stretched elastin (49).
Each branch and change in vessel wall composition is important in the 
haemodynamics of blood flow. Pressure waves transmitted from the heart are altered with 
changes in vessel wall properties and reflected at bifurcations and terminal arterioles, 
which can be regarded as an obstacle to flow. Since William Harvey, the precise 
information on the effect of the different components, size, branches, and physiological 
control of the circulation have been investigated to determine the effect BP and flow have 
on the design on the arterial vessels. Throughout the arterial vasculature, the cellular 
make-up and regulatory mechanisms are appropriate for the pressure and flow that the 
segment is subjected to. Therefore, it is important to study the segments of the arterial 
vasculature separately to understand the parameters regulating pressure and flow in each 
area. The changes through aging and disease have yet to be fully elucidated.
2.3 Components of the Arterial Tree to Regulate Blood Pressure and Flow
The concept of haemodynamics is concerned with the relationships governing
pressure, flow, and volume within the cardiovascular system. The amount of blood flow 
that is delivered to various parts of the body is controlled by many different mechanisms. 
Most importantly, blood flow follows BP and the mechanisms regulating BP are valuable
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to understand blood flow. Arterial PP is an important signalling hemodynamic parameter 
regulating blood flow.
BP is comprised of two components: steady state and pulsatile (109; 210). The steady- 
state component is characterized by the MAP, which represents the product of Q and 
peripheral resistance (161). The pulsatile component is determined by the left ventricular 
ejection and stroke volume (SV), as well as the compliance, or elasticity and recoil, of the 
arterial circulation (120). The elastic wall of the aorta transforms the pulsatile on-off 
blood flow of the left ventricle into the less pulsatile flow of the distal arteries (137). 
During each cardiac cycle, arteries exhibit oscillations in diameter as arterial pressure 
causes arteries to distend circumferentially.
Kember and colleagues (2004) demonstrated that this dynamic pattern of PP is 
determined by downstream conditions, or information from the periphery, as global 
information is required for adequate cardiovascular control (93). This study demonstrated 
that peripheral vascular mechanics can alter blood flow in the central aorta. The periphery 
controls the speed of the reflected wave that will merge with the forward wave in the 
aorta, thus affecting BP and flow in the central arteries.
Forward pressure waves generated from the heart can be reflected at branching points, 
areas of alteration in arterial geometry, or terminal arterioles, and parts of the wave are 
reflected upstream to alter blood flow in the aorta. Reflected waves travel backwards with 
approximately the same speed as the forward-flowing wave and, at some point through 
the aorta and its branches, the incident and reflected waves are traditionally thought to
summate. The wave speed of the forward and reflected wave depends on the diameters, 
lengths, and elasticity of the vessels (137; 140; 179).
Pressure wave reflection may serve at least two beneficial purposes (109). First, the 
reflected wave returns to the central aorta in diastole, thereby enhancing the diastolic 
perfusion pressure in the coronary arteries (137). Secondly, wave reflection limits the 
transmission of pulsatile energy to the periphery where damage to the microcirculatory 
beds might occur (162).
However, in a stiffer system, the wave speed of the reflected wave is increased. This 
increased wave speed may diminish wave reflections or cause wave reflections to return 
earlier, and may lead to augmentation of systolic pressure due to the fusion of the forward 
and reflected waves earlier in the cardiac cycle (137; 202). A stiffer vascular bed 
produces less buffering of systolic blood pressure (SBP) and less recoil in diastole 
resulting a greater fall in diastolic blood pressure (DBP). This increased systolic pressure 
and reduced diastolic perfusion may limit steady state flow in the coronary circulation 
and increase transmission of pulsatile energy into the microcirculation (162).
Figure 2.1 demonstrates how the downstream vasculature can affect the dynamic PP 
in the upstream central vasculature. Specifically, a stiffer vascular bed will cause faster 
reflected pressure waveforms that backup towards the heart. If they travel faster, as in a 
stiffer vessel, they will reach the heart earlier in systole, causing a higher systolic 
pressure. In cases of aging or diseased vessels, the constant augmentation in BP may lead 
to vascular remodelling. Thus, through pressure distribution, the effect of peripheral 
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Figure 2.1 - Forward and reflected waves are determined by the stiffness or compliance 
of the arterial walls. The recorded pressure waveform is the summation of the forward 
and reflected waveforms. The downward arrows indicate the location of the reflected 
wave.
The peripheral and central vascular mechanics and regulation of BP are controlled by 
both passive and active properties. Therefore the mechanical, anatomical, and physical 
properties of the vessel are important to understand the mechanics that regulate the blood 
vessels’ ability to distribute changes in pressure.
2.3.1 Passive Properties
Elastic modulus, an engineering term to describe the deformation of an object when a 
force is applied to it, indicates the elasticity or ability of an object to return to its original 
shape and size (137). The elastic modulus is high for collagen and low for elastin. Since 
collagen is a stiff, high elastic modulus fibre whereas elastin is easily expanded and 
returns to its original form, it has been suggested that the relative proportion of elastin and 
collagen directly determines the overall elastic modulus of the different blood vessels 
(55). The ratio of collagen to elastin is suggested as a useful index to determine the
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compliance of the arterial wall (50; 179). The large, conduit arteries are mainly composed 
of elastin, whereas the smaller arteries have higher concentrations of collagen as the 
constituents of the vessel wall differentiate depending on the haemodyanmic stresses that 
it is subjected to (168) (Figure 2.2). In a cylindrical blood vessel, the BP within the 
vessel, tending to distend the wall, is resisted by the tension in the wall (37). The balance 
of these two opposing forces is expressed by Laplace’s Law which states that:
T = P*r; where T is the total tangential tension in dynes per centimetre length of the 
vessel, P is the pressure in dynes per square centimetre, and r is the radius in centimetres. 
It has been suggested that the absolute level of tension determines the collagen content in 
the vessel wall and that the rate of change of tissue tension determines the elastin content 
(137). The regulation of wall tension is a main determinant of travelling waves as both 
forward and reflected waves are determined by the elasticity of the vessel walls.
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Figure 2.2 - Variety of compositional components of the four tissues of difference blood 
vessels. The first number under the artery name is the diameter of the lumen. The second 
number is the thickness of the wall (37).
While Laplace’s Law identifies some factors that contribute to the mechanical 
properties of blood vessels, it does not account for other factors (in addition to simply the 
passive properties), or the total amount of connective tissue proteins present. Although 
studies have demonstrated a close agreement between the collagen-elastin ratio of blood 
vessels and mechanical properties of both normal and diseased vessels, this relationship 
does not hold for peripheral arteries (55; 179). Since large variations in composition occur 
in these arteries, it can be concluded that other factors, such as the active properties of the 
arterioles, contribute to the determination of the mechanical properties of blood vessels in 
addition to simply the total amount of collagen and elastin present (179).
2.3.2 Active Properties
Changes in the pressure and flow through the vasculature signal various reflex 
mechanisms that alter the structure, growth, and differentiation of the vessel wall. These 
active mechanisms of vascular control are regulated neurally, mechanically, and 
chemically.
2.3.2.1 Neural Factors
Neurally mediated reflex control mechanisms play an important role in the control of 
arterial BP and the distribution of Q. Stimulation of the sympathetic nerves to a vascular 
bed usually produces a reduction in blood vessel diameter and increases the resistance in 
the vascular bed (38; 70). The sympathetic division of the autonomic nervous system 
innervates the entire arterial tree down to the smallest arterioles (53; 161). The arterioles 
are highly innervated by the sympathetic nervous system and represent a level for greater 
control compared to the larger arteries (138). Therefore it is important to measure blood 
flow changes both centrally and in the periphery.
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Though the sympathetic nervous system was previously believed to control the 
vasculature via changes in resistance only (38; 70), this concept deals primarily with a 
constant flow model of the circulation, whereas blood flow is pulsatile (210). In recent 
years, it has been increasingly recognized that the compliance of blood vessels may be an 
important property regulating the control of blood flow (105; 161; 183; 210). Supporting 
this notion, previous work on the neurovascular control of blood vessels has shown that 
the sympathetic nervous system can affect the compliance of a blood vessel without 
changes in vessel diameter (165; 211). A change in the compliance of a blood vessel will 
affect the rate of blood supply to a vascular bed (210) as a reduced compliance may 
decrease the transit time of blood flow through the circulation.
2.3.2.2 Mechanical Factors
An intrinsic property of the arterial vasculature, and more specifically smooth muscle 
cells, is the myogenic response which was identified by Bayliss in 1902 (22). If the 
smooth muscle cell is stretched, it responds by contracting. This feature provides 
automatic responsiveness to changes in mechanical load (137).
The myogenic response is capable of regulating blood flow since the vessel wall of 
regulatory vessels is predominantly composed of smooth muscle cells and therefore a 
change in pressure will affect the vessel diameter. In addition to the local changes, the 
myogenic response feeds back to the systemic BP and contributes to the protection of 
fluctuations of pressure (27; 50; 85). This is achieved by the change in wall tension, 
signalling membrane depolarization, and an influx of calcium via opening of voltage 
operated calcium channels. This promotes myosin actin interaction and vasoconstriction 
occurs (167). Although the myogenic response is thought of as a vasoconstrictive
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response only, altering transmural pressure has been shown to change compliance without 
a change in resistance (58; 211).
23.2.3 Chemical Factors
Various substances, such as hormones, blood borne factors, and endothelial derived 
molecules are vasoactive and can attenuate or augment mechanical and neurogenic 
effects. These metabolites can have direct or indirect actions on the vessel wall.
Hormonal control of blood vessels plays an important role in the control of the 
cardiovascular system. There are a number of hormones that when released into the 
blood, produce significant effects on vascular diameter and elasticity. Catecholamines are 
released from the adrenal medulla, and circulate through the blood during sympathetic 
stimulation and have both direct and indirect effects on the vessel wall (161).
Sex hormones also affect vascular control and may account for some differential 
responses between men and women. Estrogen, a hormone present in both sexes but at a 
higher concentration in women, is a vasodilatory stimulus (76; 128). Testosterone, 
another hormone present in both sexes, can be converted to dihydrotestosterone by 5 a- 
reductase or to estrgoen by aromatase (114). Circulating levels of testosterone are 
generally high in men and low in women and testosterone and its conversion to 1713- 
estradiol is important in both men and women as a key sex steroid (128). The conversion 
of testosterone to 17P-estradioal via aromatase, is an important source of estrogen, as it 
represents approximately 80% of available 17p-estradiol in men and may contribute to the 
regulation of vasodilator function in men (106; 128). The estrogen-induced vascular 
relaxation pathways involve changes in the synthesis, release, and thus bioavailability of
EDRFs such as nitric oxide, prostacyclin, and the endothelium-derived hyperpolarizing 
factor (52; 77).
In addition, estrogen supplementation has been reported to maintain or improve 
arterial compliance (43; 92; 155). Zhang e t a l. (2001) reported that endogenous estrogen 
mediates vascular reactivity and distensibility in pregnant rats (215) and estrogen 
replacement reduces age-associated remodelling in normal rats (214). It was further 
demonstrated that high expression of alpha estrogen receptors are correlated with a lower 
collagen concentration as well as the stiffness of human uterine arteries (111). This 
estrogen mediated protection against increased collagen may improve vessel distensibility 
and compliance. However, the effect of estrogen on vascular stiffness may not be 
homogeneous in different regions of the vascular bed as estrogen treatment increases 
aortic stiffness and potentiates endothelial vasodilator function in the hindlimb, but not in 
the carotid vascular bed of rats (186).Therefore, the concentration of estrogen in both 
males and females will affect vasodilatory function, vascular geometry, and vascular 
stiffness.
These components regulating vascular mechanics work independently and 
dependently with one another depending on the availability and interaction between these 
mechanisms. Understanding how these components regulate vascular mechanisms is 
important to study the changes that may occur in the control of the cardiovascular system 



















Figure 2.3 Summary of major neural, mechanical, and chemical factors that determine 
various properties regulating blood flow in the skeletal muscle circulation. Factors 
causing constriction are shown in black and dilatory factors are shown in gray. Ang II, 
angiotensin II; AVP, arginine vasopressin; Epi, epinephrine; ATP, adenosine 
triphosphate; ANP, atrial natriuretic peptide, BNP, brain natrieretic peptide; NE, 
norepinephrine, NPY, neuropeptide Y; TXA2, thromboxane; ET-I, endothelin-I; 02-, 
superoxide; NO, nitric Oxide; PGI2, prostacyclin; PGE2, prostaglandin E2; EET, 
eicosatrienoic acid; CO, carbon monoxide; H202, hydrogen peroxide; AM, 
adrenomedulin. (Adapted from reference 131)
2.4 Properties of Steady State and Pulsatile flow in Central and Peripheral Vascular
Mechanics
The factors regulating vascular mechanics have been discussed briefly in the above 
sections and although the vessel wall components and neural, mechanical, and chemical 
inputs will alter vascular mechanics, simply studying these factors do not identify the 
parameters regulating blood flow to supply the living organism. A more integrated view 
of vascular mechanics considers both the steady component and the pulsatile component.
To ensure adequate delivery of blood flow for metabolic exchange, the conduit 
arteries need to deliver enough blood to the periphery and tissues (179). The steady 
component is the average of conditions and is based on the resistance of the vascular tree 
(12). To maintain a steady flow, pressure, indicated by MAP, must overcome the 
resistance of the downstream vasculature (137). This resistance is most often defined as 
total peripheral resistance (TPR) and refers to the diameter of the downstream 
vasculature. TPR is equal to MAP divided by Q. This relationship is known as Ohm’s law 
and represents the factors regulating steady state flow (137). The components regulating 
the diameter and thus mean pressure and resistance were discussed in previous sections.
Steady state refers to the average flow and assumes that flow does not vary with time, 
which in fact is not true of arterial flow. It is generally taught that the control of 
peripheral blood flow is regulated by a change of peripheral resistance based on 
Poiseuille’s law. These assumptions are not directly related to in vivo conditions as 
arterial flow is pulsatile and the diameter of the arterial vessel changes within each 
cardiac cycle (210). Although important, resistance cannot be the only parameter 
determining blood flow, because if this were the case, the flow waveform would be 
similar to that of pressure; but it is not (Figure 2.4). In as early as 1943, Shipley e t a l. 
studied pulsatile flow patterns in a wide range of arteries and found no clear relation 
between the pressure and flow waveforms (170). In all areas of the circulation it can be 
seen that this is not the case and other mechanisms regulating the dynamic or oscillatory 
components of blood flow must be important (210).
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Average Pressure Waveform Average Flow Waveform
Figure 2.4 Pressure (Left) and Flow (Right) Waveforms. If resistance was the only 
parameter regulating blood flow, the shape of the waveforms would be similar. This is not 
the case and other parameters must contribute to blood flow.
The compliance, or elasticity, of the vessel wall is another parameter affecting 
pulsatile blood flow (210). Vascular compliance is determined by the change in volume 
(or diameter) of a blood vessel segment for a given pressure change (179). Vascular 
elasticity is determined by factors that regulate the diameter of a blood vessel and the 
elastic components in the vessel wall. The compliance is an important property as when a 
blood vessel is stretched, it stores blood volume, and then can recoil to 'push' the blood 
flow further down the tube.
Compliance is not only regulated by passive properties; compliance can be affected 
by myogenic tone, as an increase in transmural pressure, such as lowering an arm below 
heart level, results in no change in R and a decreased C (58; 211). In opposition, 
decreasing transmural pressure by raising one’s arm above heart level increases C without 
a change in R (58; 211). Only recently has it been shown that the sympathetic nervous 
system may affect the compliance of the blood vessel as well (33; 165; 184).
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While compliance refers to the pure elastic component of the vessel wall, the vessel 
wall actually behaves similarly to a spring moving on a surface with friction. For 
perfectly elastic materials, the force developed in response to a length change is 
independent of the rate at which length is changed (179). However, this is not the case in 
the vessel wall. Vessel walls are not perfectly elastic as they do not retain their original 
form when a force is removed, nor do they retain the deformation, a property of plasticity 
(179). Therefore, the deformation will depend on both the magnitude of stress and on the 
rate that this stress is applied (137). Blood vessels exhibit properties appropriate to both 
an elastic and viscous body and therefore are termed viscoelastic (210; 211).
The viscoelastic property of the vessel wall refers to the parameter that modulates 
changes in compliance. Viscoelasticity is characterized by the phase difference between 
the applied force, or pressure, and resulting wall displacement (25). This property gives 
the force with which a material resists a change in its volume or diameter (37) and is 
partly regulated by passive elements of the vessel wall (137). This load-bearing 
mechanism of the vessel wall is an important parameter regulating blood flow.
When smooth muscles are rapidly stretched, they exhibit a sharp rise in tension 
(resistance to stretch), which then decays (stress relaxation) over time (172; 173). 
Siegmen (1976) noted that this resistance to stretch and resulting stress relaxation were 
markedly affected by the presence or absence of calcium. This calcium dependent 
response was not through membrane potential, alpha adrenergic receptors, or intracellular 
calcium, but may be due to calcium sensitivity. This myogenic response is a property of 
smooth muscle cells and related to the contractile elements (67). The myosin-actin 
crossbridge attachments may direct this mechanical response and contribute to the
resistance to stretch. When the muscle is stretched, the breaking and subsequent 
reformation of attachments may not generate a net force in the resting state, but may 
determine the magnitude of stress resistance and relaxation (173). Therefore the number 
of cross-bridges attached and extent of actin-myosin overlap in accordance with the 
sliding filament theory, may govern this response (172; 173). Recent work from our 
laboratory also suggests that the sympathetic nervous system may contribute to the 
viscoelasticity of the vessel wall (58; 116). Therefore it appears that both active and 
passive properties may regulate the viscoelasticity of the vessel wall.
The final parameter often studied in the context of pressure -  flow relationships is the 
inertia of the blood and of the vessel wall (210). The mass of a fluid may be thought of as 
being at rest at the start of the cycle -  as it is in diastole in the left ventricle (36). When 
the heart muscle contracts, pressure is generated, yet the fluid will resist movement 
because of its inertia. Fluid inertia is another form of resistance to flow, as there is a time 
delay to achieve the appropriate flow rate. This transient response attempts to match the 
flow with the pressure difference. However, due to pulsatile flow, this pressure difference 
is always changing and thus, the flow does not reach its appropriate rate. The higher the 
inertia, the longer it will take the flow to reach steady state. Inertia of blood in 
physiological conditions is not well studied, but is regarded as an important parameter 
regulating blood flow (210).
2.5 Measuring Parameters and Changes in Central and Peripheral Vascular
Mechanics
Numerous models and methods have attempted to study the vasculature and the 
parameters regulating blood flow. However, most methods can only determine the steady 
state, or average of conditions. Other methods can quantify some dynamic parameters,
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but are applied only within a given arterial segment. These local parameters may not be 
indicative of the vascular tree, central or peripheral. As previously discussed, the 
importance of segmenting the vascular tree is extremely valuable in detecting peripheral 
and central parameters as peripheral vascular mechanics dictate central recordings. 
Limitations occur as, historically, central vascular mechanics are studied on a global scale 
and local measures are limited to conduit arterial segments due to the capacity of the tools 
that are available. Peripheral vascular mechanics are inherently difficult to study due to 
the complex and small nature of these vessels. This section will summarize current 
methods and a novel method to study the parameters regulating blood flow in the 
systemic vascular, the local vessel, and vascular bed.
2.5.1 Methods for Systemic Vascular Compliance
PWV has been hailed as the best method to study vascular compliance as it is easily
measured non-invasively, highly correlated to various diseases, and may serve as a 
marker of atherosclerosis (6; 137; 142). PWV, a measure of the speed at which the 
forward pressure is transmitted between two locations is used as an index of arterial 
stiffness (1). PWV is affected by heart rate (HR), vessel compliance, and BP (6). As HR, 
stiffness, and BP increase, the pulse wave travels faster due to a decreased arterial 
compliance. Increased PWV indicates decreased arterial compliance and systemic arterial 
stiffening (28).
PWV is calculated as the distance between recording sites divided by the 
transmission time of the arterial PP wave between the two sites (pulse wave transit time) 
(Figure 2.5). The pressure or flow wave, recorded simultaneously at two sites, can be 
recorded using pressure-sensitive transducers, applanation tonometrey, Doppler
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ultrasound, and many other devices. PWV can be calculated between any two sites, such 
as heart to finger, heart to toe, femoral to toe, etc. The resulting PWV indicates the 
stiffness of the arteries between the two sites. This tool allows for us to study different 
areas of the systemic arterial vasculature (6).
Figure 2.5 Measurement of Pulse Wave Velocity from a sample set of data. Distance is 
recorded as the distance between the two recording sites, the heart to finger. Pulse wave 
transit time is measured from the R-peak measured from the heart rate (proximal site - top 
panel) recorded from an electrocardiogram to the foot of blood pressure at the finger 
(distal site - bottom panel) recorded from the finger finometer.
Identifying the start and end of the pulse wave transit time poses some limitations to 
this method. Using the peak pressure may provide inaccurate timing in some conditions 
as the peak may be augmented by a stiffer system and therefore will exacerbate the 
reduced pulse wave transit time (109). The foot of the pulse wave is the most accurate 
location as it is unaffected by wave reflections (6; 137). Another limitation of this method 
is the use of the R-peak as the initiation of pressure. The true point of origin in PWV is
the initiation of pressure with ejection of blood from the heart. This does not occur 
directly at the R-wave but a few milliseconds after left ventricular depolarization, the so- 
called pre-ejection period. Heart contractility affects SV and pressure initiation, and, 
therefore, in conditions where heart contractility is altered, using the R-peak may over or 
underestimate arterial compliance (1). SV, recorded from the suprasternal notch, or 
cardiac velocity, both measured by Doppler ultrasound, may be a more ideal indication of 
the start of pressure during a cardiac cycle (82). Another error may occur when estimating 
the distance between the two sites as surface measurements may not accurately reflect the 
actual arterial distance. For example, distance measures assume that the aorta is straight. 
Different studies have used various points for measurement and therefore there is no 
standard across multiple studies.
Pulse contour analysis is another measurement of arterial stiffness. This method 
distinguishes between the forward and reflected waves based on the foot on the reflected 
wave. The time from the forward wave foot to the reflected wave foot is related to aortic 
PWV (109; 145) and a decrease in transit time indicates aortic stiffening. However, when 
conditions that alter the augmentation index such as alterations in HR, BP, heart failure, 
or drug therapy are not equal between groups, this tool can only be regarded as a 
manifestation of wave reflection and should not be used (137; 201).
Another method using an adapted Windkessel model, applies an algorithm for the 
diastolic portion of an arterial wave and segments central and peripheral compliance (122; 
198). However, in conditions where arterial compliance is decreased and wave reflection 
occurs during systole rather than diastole, this analysis is inaccurate (109). Determination 
of the waveform is difficult because changes in the pressure pulse contour occur as the
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wave propagates. Another limitation is that a pressure difference between central and 
peripheral arteries is not accounted for (145).
Techniques that provide information about small artery properties must be 
interpretted with caution. Izzo e t a l. (2001) investigated the correlation between three 
measures of arterial stiffness: systolic pulse contour analysis, diastolic pulse contour 
analysis, and cuff plethysmography (83). This study showed absent or weak correlations 
between these variables. In another study, although good agreement was noted between 
some variables (augmentation index, PWV, central and brachial PP), poor agreement was 
noted between other ‘small artery’ variables. A more accurate model is required to study 
peripheral vascular mechanics.
2.5.2 Local Vascular Compliance
Numerous equations exist to determine local changes in vascular compliance. Local 
arterial stiffness relates changes in arterial diameter to pressure changes at an arterial 
segment of interest (91). The changes are based on end-diastole and end-systole diameters 
assessed by ultrasound, whereas pressure is most accurately measured by applanation 
tonometry at the site of interest. Based on recommendations of an international group at 
the First Consensus Conference on Arterial Stiffness (145), measurements of pressure and 
diameter, the best indicators of local stiffness can be expressed as: Distensibility (1), 
Compliance (2), Peterson’s Elastic Modulus (3), Strain (4), and Stress (5) (Table 2.1).
28
29
Table 2.1 Local Arterial Stiffness Equations
Equation
DiameteisvcTni F -  Diameternusmi f 
(PressureSYST0LE -  PressureDIASTOLE) * DiameterDIAST0LE
DiametersvcTni f -  Diameternusmi f 
(PressureSYSTOLE -  PressureDIASTOLE)




3) Peterson’s (PressureSYsTOLE -PressureDIAST0LE) * DiameternlAST0LE
Elastic Modulus (DiameterSYSTOLE -  DiameterDIASTOLE)
(mmHg)
Definition
Relative change in 
diameter for a given 
change in pressure
Absolute change in 
diameter for a given 
change in pressure
Pressure change 




4) Strain Diameter̂  vstoi f -  PiameternnsToi f 
D iameter d i Astole
Relative change in 
Diameter
5)Arterial Stiffness lnffressurewymi F /Pressurenixnm F) * DiameternlAST0LE Ratio of logarithm
(DiameterSYST0LE -  DiameterD|ASTOLE) (systolic/diastolic
pressures) to relative 
change in diameter 
[stress to strain ratio]
However, these measurements are limited to arterial segments from which diameters 
can be accurately determined using ultrasonic imaging. It is essential that proper training 
exists for the sonographers to ensure high reliability (63; 64; 171).
Arteries are not homogenous tubes, and compliance can vary in different parts of the 
same vessel (164). For example, in older subjects, the decreased distensibility of the 
carotid artery is most pronounced in the carotid sinus (164) and therefore results in one 
vessel segment may not reflect the arterial system.
2.5.3 Lumped Models to Study the Entire Vascular Bed
The compliance of the small arteries is inherently difficult to study non-invasively in
vivo. In the absence of adequate tools to assess the microvasculature in vivo, a model
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that can be compared to measured variables is an ideal alternative (12; 210). In an attempt 
to segment out peripheral vascular mechanics, a lumped or Windkessel model has been 
used to investigate parameters regulating blood flow in the peripheral vascular bed (201). 
The Windkessel model is a simplification of the arterial system and describes the whole 
arterial system downstream of the location where measurements are obtained (201).
The first model, or the Frank two-element Windkessel model, was composed of R 
and C. R was calculated based on Poiseuille’s law and C was determined by the elasticity 
of the arteries (163). Although this model did not rely solely on R and incorporated C, it 
was not able to predict pressure and flow during systole (201). Therefore, newer 
Windkessel models introduced a third component, impedance. Impedance, calculated as 
the wave speed times blood density divided by cross-sectional area, is another parameter 
regulating pulsatile flow (210). However, these models are still not adequate in describing 
other important components regulating blood flow (181). Other investigators have 
attempted to create a four-element model but the incorporation of inertance proved to be 
difficult and limitations existed. All of these models missed the viscoelastic property of 
blood flow. In 2007, Burattini and Di Salvia found a model that incorporates 
viscoelasticity to resolve some limitations predicted from other models (36). The 
incorporation of viscoelasticity allowed a new paradigm for development o f a new 
modified Windkessel model.
2.5.4 RCKL Model
The most sophisticated, yet simplistic enough for rapid interpretation, modified 
Windkessel model incorporates the four elements of R, C, K, and L (211). This model 
provides a relation between pressure and flow and is able to predict the flow wave form
that would be produced by a given (measured) pressure wave. The calculation of a 
modelled waveform uses an electric circuit analogy given by total impedance (Z) of the 
system (Equation 1) where go is the frequency of oscillation of the prevailing pulsatile 
flow and i =V(-1) (210).
Equation 1: Z= RJtoKC + i(a>2L C  -  111 
coC(K + R) + /(co2LC-1)
This predicted wave is then compared to the measured flow waveform to achieve 
congruency between the two waves. R, determined from the average pressure waveform 
divided by the average flow waveform, is held constant, while C, K, and L are modified 
until a modelled waveform is achieved that resembles the measured waveform. The most 
accurate model can be determined by the lowest error value that is determined by the sum 
of the differences squared between the two waveforms at each point along the wave 
(Figure 2.6). This process is automated using MATLAB programming and Fourier 
analysis transform techniques (34; 210; 211) (Figure 2.6).
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Figure 2.6 RCKL Model. A. Set of data obtained from a subject. ECG 
(electrocardiogram, heart rate); pressure (Finometer, brachial blood pressure); flow 
(Doppler ultrasound, brachial blood flow). B. Pressure and flow waveforms are averaged 
over the data set to determine Resistance. C. Resistance, held parallel to compliance (C), 
viscoelasticity (K), and inertia (L) all in series. Resistance determined from average 
pressure and flow waveforms is held constant while C, K, and L are modified. D. A final 
modeled (dashed) is achieved that is congruent to the measured (solid) flow waveform 
and values of C, K, and L are obtained (210; 211).
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Examinations of the central or large arterial vascular mechanics dominate the clinical 
literature. This is due to the limitation of our knowledge understanding the dynamics of 
the peripheral vasculature. While the contributions of C have been studied locally or 
systemically, pulsatile vascular mechanics are also important and the relevance of such a 
model is valuable to detect alterations in the dynamic components of blood flow in 
isolated vascular beds. With this new model, we will be able to detect alterations in 
peripheral dynamics using the RCKL model. Attempts to investigate peripheral vascular 
mechanics, based on this new model, in disease states, have not been investigated.
2.6 Interim Summary
Vascular research has focused on the central, large elastic mechanics regulating BP 
and blood flow. This limits our understanding of vascular mechanics as many changes are 
expected to develop in peripheral vascular beds. This review has demonstrated that the 
neurogenic, myogenic, signalling molecules, and geometry of the central and peripheral 
blood vessels are in fact different and therefore it is essential to understand both the 
steady and oscillatory dynamics of the entire vascular tree. Additionally, the alterations to 
the arterial tree and especially to the peripheral vascular mechanics in vascular disease are 
not well known.
The inadequate understanding of the periphery is due to the limitations of studying 
these small vessels in vivo. Recently our lab has developed a model to study the 
peripheral vascular bed using a mathematical Windkessel model. This model incorporates 
the R, C, K, and L of the downstream vasculature. These parameters are regulated by both 
the passive and active properties of the blood vessel. The ability to detect changes in these 
parameters, namely R, C, K, and L may help improve detection of vascular disease.
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2.7 Vascular Disease
Vascular disease, characterized by factors that alter the structure and/or function of 
arteries, is the leading cause of death in the general population (153). Vascular disease is 
a generic term and a form of cardiovascular disease that affects the blood vessels (137). 
Vascular disease often arises from atherosclerosis, the presence of arterial wall thickening 
and loss of elasticity, which characterize the presence of these vascular remodelling 
alterations (71).
Changes in arterial structure and anatomy affect the areas discussed in the previous 
sections. Various pathophysiological changes occur through the progression of vascular 
disease and are well documented. Although these changes in the vessel wall are well 
characterized during the progression of vascular disease, the alterations in the peripheral 
vascular bed dynamics have not been studied. The importance of investigating the 
properties regulating blood flow in the periphery is demonstrated by the mechanisms by 
which antihypertensive drugs act. These drugs decrease arterial stiffness through an effect 
on small arteries (194; 194) and therefore the periphery represents another important area 
to study.
2.7.1 Risk Factors for Vascular Disease
As one ages, manifestations of vascular disease become prominent (100; 126).
However, young individuals appear to be protected from age related risks of developing 
vascular disease. Although the initiation of this age-associated risk is difficult to pinpoint, 
it appears that this risk begins in one’s forties (41; 143; 144). Other risk factors negate the 
‘protection effect’ in the young and/or accelerate the rate of age-associated risks. One of 
the most important advances in diagnosis has been the identification of these major risk
factors for cardiovascular diseases, which arose from large prospective cohort studies 
such as the Framingham Heart Study and the Seven Countries Study (94; 205).
The number one preventable risk factor for vascular disease is cigarette smoking. 
Other major modifiable risk factors include high BP, high cholesterol and fat levels, 
diabetes mellitus, and a sedentary lifestyle combined with obesity (71). Uncontrollable 
risk factors such as family history and gender can also affect an individual’s likelihood of 
developing vascular disease. Men are two to three times more vulnerable than 
premenopausal women. However, postmenopause, women no longer exhibit advantages 
over men (96).
2.8 Smoking and Vascular Disease -—
In Canada, seventeen percent of all deaths in 2002 were attributable to smoking and
twenty nine percent of all smoking-related deaths were due to heart disease and strokes 
(157). Beyond the already well-established strong causative relationship with cancer, 
smoking increases the risk for vascular disease (206). Smoking may directly or indirectly 
act on various risk factors contributing to the development of vascular disease and 
represents an interesting population for studying vascular disease.
Epidemiologic studies have identified smoking as a major cause of preventable 
cardiovascular mortality (188). One of the main adverse consequences of smoking is the 
progression of atherosclerosis and cardiovascular disease (78; 84; 164). Howard e t al. 
(1998) determined that cigarette smoking was associated with a 50% increase in the 
progression of atherosclerosis (78). The risk of vascular disease increases with the 
number of cigarettes smoked (10; 51; 133; 148; 149). However, not all studies have 
determined this relationship and even low-tar and light cigarettes have been shown to
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increase the risk of cardiovascular events (13; 21). Ultimately, cigarette smoking is 
associated with an elevated risk of mortality (84). By the age of 60, the risk of having 
severe carotid atherosclerosis for a person who had smoked 40 years, was approximately
3.5 times more compared to an individual who had never smoked (203) (Figure 2.7).
Figure 2.7 Calculated adjusted odds ratio for likelihood of having severe carotid 
atherosclerosis as function of age and years of cigarette smoking. Odds ratio of 1 was 
arbitrarily assigned to 40-year-old person who had never smoked. (203)
2.8.1 Progression of Vascular Disease
The importance of hemodynamic forces in the development of vascular disease is 
documented by the presence of atherosclerosis. Atherosclerosis is a progressive disease 
associated with the accumulation of lipid, cellular metabolites, and thickening of the 
intima in vessel walls (44). An IMT in the carotid artery of greater than 1mm is 
characterized as thickening and patients with a mean IMT of over 1.15 mm have a 94% 
likelihood of developing coronary artery disease (89). Intima thickening and plaque
formation is a response due to increased inflammatory markers present in the systemic 
vasculature (108).
Excessive intima thickening gives rise to the formation of atherosclerotic lesions 
which cause degeneration of the artery walls. This plaque formation results in obstructed 
flow and thus decreased delivery of essential nutrients and oxygen. Finally, the plaque 
may rupture causing the formation of clots and/or a stroke, which is unfortunately often 
the first sign of the disease (168). The build up of plaque is often found in areas of 
disturbed flow such as bifurcations and branches in the circulation (137; 179). McGill 
(1988) reported that in smokers the abdominal aorta and carotid arteries were more 
affected than the coronary arteries (119). Clinically, the presence of plaque build-up and 
atherosclerosis identifies the presence of vascular disease (14).
Cigarette smoking produces a dose-related thickening of the intima-media of the 
arterial vasculature and heavy smokers exhibit significantly increased IMT in the carotid 
(150) and coronary arteries (9; 10) compared to non-smokers. Cigarette smoking 
increases vascular inflammatory markers related to increased fat, cholesterol, and plaque 
build up at the arterial wall (23; 26). The increase in IMT and inflammatory markers are 
evident in smokers who smoke light or regular cigarettes demonstrating the negative 
effect of all cigarette types (13).
2.8.2 Changes in Vascular Mechanics in Smokers and Vascular Disease
The presence of atherosclerosis in the systemic vascular system is not the only
documented alteration present in vascular disease. Arterial vessel walls are the primary 
site of disease and represent a target for demonstration of functional and structural 
alterations (115; 166). Arterial stiffness denotes alterations in the mechanical properties
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of arteries and has become one of the most popular studied characteristics in disease 
states. Arterial stiffness is a broad term incorporating both the compliance and 
distensibility of the arterial vessels.
Arterial stiffness increases the risk and presence of vascular disease due to the stress 
on the vessel wall. Increased stiffness decreases the buffering capacity of the arterial tree 
and thus increases the afterload on the heart (109). In patients with hypertension, large 
artery stiffness indicates the presence, but also the severity and extent of atherosclerotic 
disease (28). Increased PWV is perhaps the easiest and most widely studied marker of 
increased systemic stiffness (74). PWV is associated with the presence and extent of 
atherosclerosis and vascular disease.
As discussed in Section 2.4.1, in a stiffer system, reflected waves arrive during 
systole rather than diastole, and BP is increased. The augmentation index, describes this 
augmented systolic pressure and alongside carotid IMT is associated with a high 
cardiovascular risk (178). PP, calculated as the difference between SBP and DBP, is 
often elevated in conditions of vascular disease (59; 112) affecting the compliance and 
distensibility of the blood vessel. Overtime, this constant baroreflex resetting and 
increased stress on the vessel walls leads to vascular remodelling and even stiffer vessels 
(93).
Acutely, smoking one cigarette decreases carotid and brachial distensibility and 
compliance (54; 97) and increases PWV (95; 98; 204). Chronically and acutely, smokers 
exhibit elevated SBP, DBP, MAP, and PP and augmentation index (54; 95; 97; 104; 107; 
112; 156). Jatoi e t  al. (2007) found a direct linear relationship between smoking status
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and arterial stiffness, with former smokers having intermediate values between current 
smokers and non smokers (87). However, other studies have not identified chronically 
elevated PWV, decreased compliance and distensibility, or elevated pressure in smokers 
compared to non-smokers (97; 112; 156; 195). The discrepancy in results may be 
accounted for by heterogeneous groups of subjects such as various age ranges, grouping 
males and females together, and/or the lack of control for confounding variables of other 
risk factors such as elevated BP, weight, and most importantly the location of the arteries 
studied. The significant variation in the designs and conditions of these studies makes 
direct comparisons difficult. In addition, no comparison has been made between central 
and peripheral vascular mechanics to our knowledge.
2.8.3 Mechanisms of Vascular Disease Progression in Smokers
Cigarette smoke expose humans to a wide range of harmful substances, several of
which have the potential impact on the process of vascular disease. At least 4700 
constituents of cigarette smoke have been identified, yet many more components are 
unidentified (65; 150). The identified components that are most often studied are: 1) 
carbon monoxide; 2) other vapour phase components; 3) tar; and 4) nicotine (175). For 
the purpose of this review, the effects of carbon monoxide, vapour phase components 
such as free radicals, and nicotine will be discussed.
Carbon monoxide passes easily from the lungs into the blood stream and binds to 
haemoglobin thereby displacing oxygen. The main mechanism by which carbon 
monoxide affects vascular mechanics is the resulting hypoxic environment. Hypoxic 
conditions have been shown to increase sympathetic nervous system activity in humans 
(72; 176; 180). Studies in rabbits and monkeys have reported that exposure to carbon
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monoxide produced an accumulation of cholesterol in the aorta and coronary arteries 
which was implicated in the process of atherosclerosis (7; 8). However, acute exposure 
did not affect plasma lipoprotein levels, mean HR, or catecholamine production (103). 
Additionally, maximal aerobic capacity and exercise tolerance are reduced by carbon 
monoxide. Therefore, carbon monoxide may have indirect effects on the vasculature due 
to weight gain and decreased aerobic capacity (118).
The vapour phase of cigarette smoke contains free-radicals which increase vascular 
superoxide production (154). Reactive oxygen species react with nitric oxide to decrease 
nitric oxide and prostacyclin availability (147; 152). This decreased bioavailability of 
nitric oxide and prostacyclin contributes to impaired vasodilation and endothelial function 
(20; 99; 141). Endothelial dysfunction, an early phenomenon in vascular disease, has 
been observed in smokers compared to non-smokers (42; 156; 204; 213). Endothelial 
dysfunction, the inability of the vessel wall to dilate in response to shear stress, is a 
consequence of decreased synthesis or increased degradation of nitric oxide and is present 
in diseased states (134). Mechanisms for decreased nitric oxide production include 
alterations in nitric oxide synthase enzyme substrate activation, changes in the endothelial 
nitric oxide synthase expression, structure, and activation, and the presence of reactive 
oxygen intermediates that inactivate nitric oxide (136).
Flow dependent dilation, a non-invasive marker of endothelial function, is 
progressively decreased with increasing plaque development on the arteries (213). In 
smokers, over the entire range of wall thickening, arterial segments exhibited even further 
reductions in dilator responses compared to non-smokers (213). Evidence of endothelial 
dysfunction and impaired nitric oxide-mediated dilation is apparent in smokers (121;
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204). However, when smokers are given nitrorusside (80), methacholine, (121) or 
glyceroltrinitrate (204) as vasodilators, they were able to dilate to the same extent as non- 
smokers. Therefore smokers exhibit a reduction in basal, but not stimulated nitric-oxide 
mediated vasodilation.
Nicotine is often documented as the most harmful substance of cigarette smoke and 
is believed to be primarily responsible for the hemodynamic effects of cigarette smoking 
(175). Nicotine increases Q, HR, BP and decreases endothelium derived vasodilation and 
nitric oxide availability (117). Nicotine and its metabolites also act as potent regulators of 
cell growth factors and thus contribute to the thickening of this intima caused by smooth 
muscle cell proliferation (40).
The response of the cardiovascular system to nicotine is mainly associated with the 
activation of the sympathetic nervous system (24; 198). Exposure to nicotine causes 
increased HR and BP via beta-2 adrenergic mechanisms and increased adrenal release of 
epinephrine and alpha-adrenergic mediated smooth muscle contraction. Data from Watts 
e t a l. (1960) indicated that nicotine is one of the most effective compounds for releasing 
epinephrine from the adrenal glands in dogs (198). A chronic increase in sympathetic 
nervous system activity resulting in vasoconstriction or decreased compliance and may 
cause vascular remodelling.
Vascular remodelling may cause alterations in the geometry of the vessel wall such 
as increases in the degradation and synthesis of collagen and the destruction and 
reconstruction of elastin fibres (11; 41). Dysregulation of the ‘normal, healthy’ 
contribution of elastin and collagen leads to increased arterial stiffness and modifications
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of mechanical properties (207). Increased collagen and decreased elastin contribution to 
the vessel wall is stimulated by a number of factors. For example, increased luminal 
pressure stimulates collagen production and the inflammatory response degrades the 
extracellular matrix by creating uncoiled, less effective collagen and broken elastin 
molecules (177; 207). Cross-link formation is altered making the vessel wall stiffer (41). 
Histological examination of stiffened arteries demonstrates this disproportionate collagen 
and elastin content of diseased vessels (11).
In smokers, studies have found altered elastin and collagen content in compared to 
non-smokers (182). Although Cox e t al. (1984) found no effect of cigarette smoking on 
the concentration of collagen and elastin in the carotid or femoral arteries following acute 
cigarette exposure in dogs, they attributed the increased stiffness to altered cross linking 
or type of collagen present (46). These studies focused on the central arteries only or were 
not able to identify the location of the remodelling. Therefore, these are limited as we 
have demonstrated the importance of structural changes in the periphery as well.
Cigarette smoking also increases smooth muscle cell proliferation and migration 
contributing to the high risk of vascular disease (40). Smooth muscle cells undergo 
alterations during the progression of vascular disease as the thickening of the intima has 
been attributed to the proliferation of these cells that migrate from the media into the 
intima (159; 169). The increase smooth cell proliferation and migration may lead to an 
altered myogenic response that is evident in vascular disease (110).
Finally, several studies have shown that smoking is more harmful in young women 
than men (139; 192). Pooled data from 3 population studies including 11,474 women and
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13,191 men indicate that the cardiovascular risk associated with smoking was consistently 
higher in women than in men (192). This increased risk was independent of age, arterial 
BP, body mass index, and physical activity.
The underlying mechanism for the increased risk in women compared to men may 
involve the antiestrogenic effect of smoking. Cigarette smoke alters estradiol metabolism, 
reduces estrogen levels, and hastens the onset of menopause by as much as 3 years, thus 
increasing the duration when women are more susceptible to cardiovascular events (18; 
75; 123; 197). Due to the different absolute risk of disease observed between women and 
men, studies grouping both sexes into one group must be interpreted cautiously.
These pathophysiological changes and alterations in vascular mechanics help identify 
individuals at risk or individuals with vascular disease. However, the identification of 
preclinical changes in the pulsatile components of the peripheral vascular mechanics may 
detect those at risk and identify possible progression by which the steady and pulsatile 
components regulating blood flow are altered.
2.9 Reversing Altered Vascular Mechanics
While the negative consequences of vascular disease have been documented and
discussed, the ability of the human body to reverse these changes is not as well studied. 
Some risk factors, such as aging and genetics related to vascular disease, cannot be 
changed; however, numerous methods to decrease the risk and development of vascular 
disease have been identified. Lifestyle modifications consistently recommended by health 
care professionals (and pertinent to this study) are exercise and smoking cessation. 
Whether these interventions may improve the central and peripheral vascular mechanics 
have yet to be elucidated.
44
2.9.1 Exercise Training
Regular aerobic exercise has beneficial effects on the vasculature as it decreases 
arterial stiffness and may decelerate the age-related increase in large-artery stiffness (61). 
Endurance trained individuals’ exhibit higher arterial compliance and decreased arterial 
stiffness compared to sedentary individuals (39; 185; 208). An increased maximal aerobic 
capacity, or V02max is associated with reduced arterial stiffness (193). In middle-aged 
sedentary men, 3 months of aerobic training increased carotid artery compliance to 
similar levels observed in similarly aged endurance trained men (185). Even in the 
smaller radial artery, higher distensibility is observed in athletes compared to sedentary 
subjects (62).
Although endurance training improves arterial compliance and distensibility, 
resistance training appears to have the opposite effect. Cortez-Cooper e t a l. (2005) 
studied women over an 11 week high intensity resistance training program (45). 
Following the training, women exhibited increased augmentation index and carotid- 
femoral PWV, both indicating increased arterial stiffness (45). However, in a lower, 
moderate intensity resistance training program, women exhibited no change in arterial 
stiffness following 12 weeks of training (208).
Exercise training is associated with an improved cardiac performance and may 
reduce sympathetic activity (125; 132; 160). Increased pulsatile flow and stretch 
associated with improved endothelial signalling and nitric oxide stimulation is also 
evident following aerobic training (5; 29; 66). However, the timing, ability to reverse 
already damaged arteries, and the effects on central versus peripheral vascular mechanics
are not well known.
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2.9.2 Smoking Cessation
Smoking cessation at any age results in beneficial effects and decreases overall 
mortality and morbidity rates from cancer and vascular disease (90). The speed and 
magnitude of risk reduction following smoking cessation is variable, with studies 
reporting 3 to 20 years required for significant risk reductions (31). The overall and 
cardiovascular mortality among former smokers approaches the level of that of a never 
smoker after 10-14 years of abstinence (90). Studies have reported that former smokers of 
1 to 10 years exhibit levels of arterial stiffness levels, measured by PWV and 
augmentation index, that fall between current smokers and non-smokers (87). After 10 
years, there was no difference in arterial stiffness between former smokers and non- 
smokers (87). In as early as one year, smoking cessation results in decreased presence of 
vascular inflammatory markers (73).
While large-artery stiffness improves following smoking cessation, the development 
and progression of aortic atherosclerosis may persist (47). Although the relative risks for 
some cardiovascular risk factors are improved, there still appears to be an increased risk 
in former smokers compared to non smokers for atherosclerosis and vascular disease 
despite the number of years one is smoke free (Figure 2.7) (203; 206).
While exercise and smoking cessation improve morbidity and mortality and display 
beneficial results on the systemic vasculature, the short-term effects are not known. These 
studies have also focused on large-artery, or central, vascular mechanics and the effect of 
lifestyle modifications on central versus peripheral vascular mechanics have not been 
studied. If early changes occur first in the periphery with smoking, their vascular 
segments may show rapid recovery with smoking cessation.
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2.10 Purpose
Based on the above background, it bears repeating that the purpose of this study was 
to investigate central and peripheral arterial vascular mechanics in young smokers and 
non-smokers. The second purpose was to determine whether these altered vascular 
mechanics can be improved following a 14 week intervention program of aerobic exercise 
and smoking cessation program.
2.11 Hypothesis
It was hypothesized that vascular mechanics will be affected detrimentally in the 
peripheral vascular bed of young smokers in the absence of central changes. This 
hypothesis predicts that, compared to non-smoking control subjects, peripheral vascular 
mechanics will be altered in young smokers. Despite these changes in the periphery, it is 
hypothesized that central vascular measurements will not be different between non- 
smokers and smokers. The second hypothesis was that these altered peripheral vascular 
mechanics can be restored in young smokers following the 14 week combined 
intervention program.
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CHAPTER 3 : TOOLS AND TECHNIQUES
To study central and peripheral vascular mechanics, the accurate collection of arterial 
pressure and velocity waveforms are required. As outlined below, a combination of finger 
based arterial pressure measures, ultrasound imaging, and Doppler ultrasound devices 
were used to study vascular mechanical properties in this study.
3.1 Brachial Artery Pressure
T'Xyf
The Finometer was used to collect pressure waveforms in the brachial artery and 
Doppler ultrasound was used to attain arterial blood flow velocity waveforms and 
diameter measures. The Finometer system obtains continuous BP waveforms from a 
finger cuff (Finometer; Finapres Medical Systems Amsterdam, The Netherlands). A 
transfer function is used to calculate the continuous BP in the brachial artery (32; 68). 
Previously, we demonstrated the accuracy of this calculation using hand-held applanation 
tonometry (211). The main components of the finger cuff are an inflatable air bladder 
and a plethysmograph consisting of an infra-red light source and a light detector. The air 
bladder is connected to the front-end unit via an air hose and both components of the 
infrared plethysmograph via a cuff cable (68).
Arterial pressure in the finger is measured using the volume-clamp method where the 
diameter of the finger arteries under the cuff is kept constant (clamped), known as the set- 
point. Changes in finger artery diameter are detected by means of an infrared photo­
plethysmography built into the finger cuff. If during systole an increase is detected in 
finger diameter, the finger cuff pressure is immediately increased to prevent a diameter 
change (30). This finger cuff pressure is, therefore, equal to arterial pressure. From this
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finger cuff pressure, an arterial brachial waveform can be calculated during each cardiac 
cycle.
A brachial BP waveform is reconstructed from finger pressure in three steps. First, the 
finger BP waveform is filtered to a brachial waveform. The systolic and diastolic levels 
on the filtered waveform are averaged over a 30 second period just before the upper-arm 
cuff is inflated, and these averaged values are used in the correction formulas. Second, the 
hydrostatic height correction is applied, and the shift in the entire waveform and its levels 
is computed. As the current study was performed in the supine position, the finger from 
which BP was measured was held at heart level. Third, the retum-to-flow (RTF) 
calibration formula is applied that uses the RTF systolic pressure just measured. The RTF 
system was developed to provide for an individual patient calibration (32). A subject’s 
individual RTF calibration shift is thus computed. After one successful supine RTF 
calibration, all pressure differences meet the requirements for proper data collection (69). 
The difference between the RTF calibration shift and the level correction shift at 
calibration time is added as a fixed and permanent shift on top of the beat-to-beat adjusted 
level correction and remains in place until a new RTF calibration is performed. The 
resulting waveform and levels are labelled RTF intrabrachial artery pressure. (68; 69).
The Finometer device also calculates a cardiac SV and cardiac output measurement, 
based on the arterial pressure waveform. This process, accomplished by the “modelflow” 
method (200), as implemented in the Finometer, computes an aortic flow waveform from 
either finger or intra-arterial pressure by stimulating a non-linear three-element model of 
the aortic input impedance. Integrating the computed aortic flow waveform per beat 
provides left ventricular SV and consequently Q by multiplying SV by the instantaneous
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HR. The relation of cross-sectional area to arterial pressure is described by an arctangent 
equation with age and sex dependent parameters based on data derived from human 
aortas and aortic impedance (101). Accordingly, the model makes use of the individual 
age, sex, height, and weight as input for the aortic area-pressure relationship to be 
simulated. The result is continuous monitoring of Q.
The accuracy of the Finometer findings are reported in numerous articles comparing 
the Finometer results with intra-arterial findings (69; 81; 174).These studies have 
identified that the Finometer is accurate and within the Association for the Advancement 
of Medical Instrumentation requirements (69).The Modelflow Q calculation has been 
compared to thermodilution Q in patients undergoing coronary artery bypass surgery and 
validated for use (86). However, some limitations have been identified as the Finometer 
system in healthy young subjects may overestimate the brachial SBP as a consequence of 
PP amplification (81). However, reconstruction of intrabrachial artery pressure from 
finger artery pressure with waveform filtering and level correction reduces the pressure 
differences substantially (69). In addition, a sphygmomanometer or manual BP 
calibration can be used on the other arm to calibrate accurate baseline readings. 
Nonetheless, the Finometer device is particularly adept at tracking beat-by-beat changes 
in BP.
3.2 Ultrasound
Ultrasound is a tool that uses high-frequency sound waves to study the human body. 
Ultrasonic imaging provides an excellent modality by which the control of blood flow can 
be studied. The ability of ultrasound to detect continuous blood flow velocity (or blood
flow when vessel diameters are incorporated) waveforms makes this tool ideal for 
studying pressure-flow relationships in vascular beds.
Sound can be propagated through almost any medium. Sound has a frequency 
(number of oscillations per second), a speed (different speeds depending on the medium), 
wavelength (distance between peaks), power/intensity (rate at which energy is transported 
by the wave through the medium), amplitude (difference between the positive and 
negative peaks), displacement, and directional [(classified as longitudinal (alternating 
areas of compression and rarefaction)] or transverse (moving perpendicular to the sound) 
features (124). The term ‘ultrasound’ refers to any sound whose frequency is above the 
audible range of the human ear (137). The frequencies used in diagnostic applications 
range from 1.5 to 15MHz (4). At these high frequencies, the wavelength of the ultrasound 
(which determines the spatial resolution which can be achieved) is small. Since 
wavelength is inversely proportional to frequency, the best resolution is achieved at the 
highest frequency. However, the attenuation of the ultrasound as it passes through tissue 
increases exponentially with frequency and the best penetration is therefore achieved at 
the lowest frequency. The net result of this conflict is that, for a given application, the 
highest frequency compatible with the required depth of penetration is used. Thus 10MHz 
ultrasound can be used with very superficial vessels, such as the carotid and brachial 
arteries, whereas lower frequencies must be used for deep-lying vessels (4; 63; 124).
3.2.1 Ultrasonic Imaging
Ultrasound is transmitted as ‘pulse-echos’ that are similar to SONAR (SOund 
NAvigation and Ranging) and RADAR. In these techniques, pulses are transmitted along 
a narrow beam which is swept through an area of interest. Transmitted energy is reflected
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and collected back to the point of origin. As sound travels at a specific velocity through 
the medium of interest (e.g., biological tissues = 1570 cm/sec) the arrival of any echo can 
be related directly to the depth of the scatterer producing that echo. In ultrasonic imaging, 
the image is built up by displaying each echo as a dot on the display screen. This intensity 
of the dot is determined by the strength (amplitude) of the echo, while its location is 
dictated by the position of the ultrasound beam and the time of arrival of the echo. By 
scanning the beam, a two-dimensional ‘B-mode’ image is built up on the display. This is 
the basis of both ultrasonic imaging and Doppler ultrasound. The brief pulses are 
produced by the piezo (pressure) electric effect. In ultrasound imaging, transducers use 
the same crystal to generate and receive the signal. Similarly, pulsed Doppler ultrasound 
uses one crystal to transmit and receive the signal. Otherwise, continuous wave Doppler 
ultrasound uses one crystal to continuously emit and another to receive continuously the 
reflected signal (124).
The piezoelectric crystal converts one form of energy into another, and in the case of 
ultrasound it converts electrical energy to mechanical vibration. The piezoelectric 
materials in the transducer will vibrate mechanically when a voltage is applied across 
them. The frequency of the voltage applied will affect the vibration frequency of the 
material. Many transducers are designed to function over a wide range of frequencies 
(124). Typically, the frequencies of 2.8 MHz to 15 MHz are used for cardiovascular 
imaging and 4-5 MHz for blood flow velocity detection. At these frequencies, ultrasound 
travels very poorly through air, and the transducers must be coupled to the patient through 
liquid, normally a gel (63). The ultrasound transmitted travels along a beam, which is 
determined by the frequency, size, and shape of the transducer. As the transmitted
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ultrasound travels through the body, it is attenuated and scattered. The form taken by the 
scattering depends on the nature of the ‘obstacle.’ Small objects, such as red blood cells, 
scatter the ultrasound weakly in all directions. However, large interfaces such as the 
vessel wall reflect the ultrasound in a single direction similar to a mirror where the angle 
of reflection is equal to the angle of incidence. Therefore the vessel wall is imaged well 
when the ultrasound strikes it at 90 degrees as the energy returns to the receiving 
transducer where it is detected and converted to an electrical signal. When an ultrasound 
pulse returns to the transducer, it will cause the transducer to vibrate, and this will 
generate a voltage across the piezoelectric element. The amplitude of the returning pulse 
will depend on the proportion of the ultrasound reflected and the amount by which the 
signal has been attenuated along its path. The arrival of any echo can therefore be related 
directly to the depth of the scatter producing that echo (189). This is the basis of both 
ultrasonic imaging and Doppler ultrasound.
3.2.2 Doppler Ultrasound
A piezoelectric crystal, when energized with an appropriate electronic apparatus, 
transmits sound at a frequency of several million cycles per second downstream along the 
flowing blood. A portion of the sound is reflected by the flowing red blood cells, so that 
the reflected sound waves travel backward from the blood toward the crystal. However, in 
arterial segments, these reflected waves have a lower frequency than the transmitted wave 
because the red cells are moving away from the transmitter crystal. The difference in 
frequency between the transmitted and reflected waves is called the Doppler Effect. This 
is the same effect that one experiences when a train approaches and passes by while 
blowing its whistle. Once the whistle has passed by the person, the pitch of the sound 
from the whistle suddenly becomes much lower than when the train is approaching. The
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transmitted wave is intermittently cut off, and the reflected wave is received back onto the 
crystal, and then amplified by the electronic apparatus. Another portion of the apparatus 
determines the frequency difference between the transmitted wave and the reflected wave, 
this also determining the velocity of blood flow (70).
The Doppler Effect occurs whenever there is relative movement between a sound 
source and a sound receiver. The observed frequency at the receiver is altered in 
proportion of the relative velocity between the course and receiver. The observed 
frequency is increased if the two structures are moving towards each other and decreased 
if they are receding. When ultrasound is reflected from a moving target, the frequency 
change can be used to detect that movement, known as the Doppler shift frequency 
(Equation 2).
Equation 2: /b=2/o(vcos0)/c;
where f 0 is the ultrasound frequency, v is the speed of movement of the scatterer, 0 is the 
angle between the direction of movement of the scatterer and the ultrasound beam, and c  
is the speed of sound propagation in the scattering medium (1570m.s for blood) (137).
When ultrasound with a known frequency (f0) is scattered by an object moving 
towards the transducer, the received echo will have a frequency which is slightly higher 
than f0. Conversely, an object moving away from the transducer will cause a shift to a 
lower frequency. The amount of this Doppler shift is determined by the original 
frequency transmitted, and by the speed and direction of movement of the scattered 
relative to the ultrasound beam. As is virtually always the case, the Doppler shift falls 
within the audible range of the human ear. Therefore with sufficient experience, it is
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possible to recognize the changes of sound associated with poor quality, and even stenosis 
or turbulence (4).
To detect blood vessels, it is seldom possible to direct the beam along the long axis 
of the vessel and there is usually an angle between the direction of the beam and the 
direction of blood movement. In Doppler ultrasound, the Doppler shift actually occurs 
twice, first when the sound strikes the target and second when it is reflected. Referring to 
the equation, it is evident that the angle of insonation strongly affects the Doppler shift. 
When the ultrasound beam is at right angles to the vessel (cos 90 degrees = 0), the 
Doppler shift frequency is zero and no signal will be obtained. At angles approaching 90 
degrees, the ability to discriminate between forward and reversed flow is impaired. 
Typically at such angles, both positive and negative Doppler shifts are detected, 
appearing equally above and below the zero-flow line. Angles exceeding 60 degrees are 
unsuitable for quantification of flow, since the rate of change of the cosine function 
increases rapidly toward 90 degrees so that small errors in angle measurement cause large 
errors in angle-corrected velocity computations. In contrast, when the transducer is 
aligned with a vessel (cos 0 degrees =1), the maximum Doppler shift will be obtained and 
angle uncertainty has its least effect. However, there are technical difficulties in obtaining 
signals at such low angles because of total reflection of sound waves at vessel walls. For 
these reasons, angles between 30 and 60 degrees are usually employed (187).
3.2.3 Validity
Ultrasonic imaging provides an excellent modality by which to study the control of 
blood flow. It is a non-invasive tool that can obtain beat-to-beat vessel diameters and as 
well uses Doppler ultrasound to obtain blood flow velocity.
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In support of other studies demonstrating the validity of ultrasound to study blood 
flow (63; 130; 187), Shoemaker and colleagues (1996) demonstrated that Doppler 
ultrasound measures of arterial diameter and blood velocity were reproducible across 
different test days during both rest and exercise conditions. Therefore ultrasound can be 
used as a reliable, non-invasive means of measuring blood flow in repeated-measures 
designs (171).
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CHAPTER 4 : METHODS
All experimental procedures were approved by the Health Sciences Research Ethics 
Board at The University of Western Ontario Ethics Committee for Research on Human 
Subjects (Getting Physical on Cigarettes, Review #16306 and Normative Vascular 
Indices Across the Lifespan, Review #16921 Appendix 1). Participants provided 
informed written consent for this study.
4.1 Subjects
Seventy-eight women (age range was 18 to 40 years, Table 5.1, Section 5.1) 
volunteered to participate. Fifty- three women participated in the Getting Physical on 
Cigarettes Program. These 53 women were smokers, defined as individuals who smoked 
more than 10 cigarettes per day for the past 2 years. In addition, twenty-five non-smokers, 
defined as women who had never smoked, served as the control group. Participants were 
requested to abstain from eating, exercise, alcohol, coffee, tea, caffeinated soft drinks and 
chocolate 3 hours before testing. Based on responses to health questionnaires, no 
participant was being treated for cardiovascular or neurological disease, allergies, and 
none consumed medications contraindicative to participation. There was no standard 
timing of measurements relative to the use of oral contraceptives or menstrual cycle.
4.2 Recruitment
Recruitment of participants was accomplished through numerous outlets: 
Advertisements were placed in local (London, Ontario) newspapers, emails were sent to 
The University of Western Ontario community, and posters were placed on campus. 
Interested participants responded to the recruitment if interested in participating. Initial 
screening took place to determine eligibility.
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4.3 Protocol Design
The first part of this study was designed to investigate the central and peripheral 
vascular effects of smoking compared to non-smoking control women. The second part of 
this study was designed to investigate the impact of smoking cessation and aerobic 
exercise on central and peripheral vascular mechanics. All participants underwent the 
same protocol to assess these parameters. Measurements of vascular health were 
performed in the Laboratory for Brain and Health (Health Science Building Room 402) 
and the Neurovascular Research Lab (Thames Hall Room 3110) as both locations had the 
same equipment. Participants in the smoking groups were tested twice, once at baseline 
and again after the fourteen week intervention described below. The control group was 
tested only once to provide reference data. All tests were performed in the exact same 
manner, setting, and design.
After arriving, participants were acquainted with the lab set-up and protocol. HR was 
determined from a standard three-lead electrocardiogram (ECG). Respiration was 
monitored by a respiratory belt. The pressure waveform at the foot was measured using a 
pulse oximeter placed around the hallux (large toe). Arterial BP was monitored 
continuously from the middle finger of the right hand by photoplethysmographic methods 
from which pulsatile brachial pressure was determined (Finometer; Finapres Medical 
Systems Amsterdam, The Netherlands). The accuracy of the calculated shape of the 
calculated brachial BP waveform has been previously confirmed in our laboratory (211). 
Automated measures were adjusted to the average of three sphymogameter BP measures 
(BPTru). A second cuff was placed on the brachial artery on the right arm. After a two 
minute recording period, a RTF calibration was performed to individually calibrate the 
upper-arm pressure with the finger pressure. Following calibration and BP measurements,
each participant rested quietly for five minutes to collect continuous ECG, finger and 
brachial BP, Q, and SV onto Lab Chart (v. 7.0 ADInstruments; Colorado Springs).
After the resting period, ultrasound and Doppler imaging was performed on the 
carotid and brachial arteries (10 MHz transducer, GE Vivid 7 and 4MHz Doppler Probe, 
Multigon Inc.). The carotid artery was imaged approximately 2 cm proximal to the 
carotid bifurcation. The brachial artery was imaged approximately 4 to 6 cm proximal to 
the medial epicondyle. A 2D longitudinal B-mode image of each artery was obtained 
which clearly showed the anterior and posterior walls. Images were stored (Echo PAC™ 
Dimension system) for offline analysis. Blood flow velocity was obtained using Doppler 
ultrasound (4 MHz, GE Vivid 7). For each location, the spectral mean velocity was 
collected and recorded for at least one minute.
•
Analog signals for hemodynamic and ultrasound variables were sampled at 1000Hz 
and collected with an online data acquisition and analysis package (Powerlab; 
ADInstruments).
4.4 Lifestyle Intervention -  Aerobic Exercise and Smoking Cessation
Eligible women who smoked were asked to take part in a supervised exercise program
three times per week for a total of fourteen weeks. Each exercise session consisted of a 
cardiovascular work-out on treadmills, stationary bikes, rowers, and/or a stepper, for 45 
minutes. Participants wore a HR monitor (Polar Electro, USA) and were asked to exercise 
at an exercise intensity that was based on a predetermined stress test to volitional fatigue. 
The participants' workload progressively increased until they were consistently exercising 
at a training intensity of 70-75% of their estimated HR max. The exercise intensity is 
classed as vigorous and this type of exercise delivery has been used in previous research
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and was related to successful short-term (151) and long-term smoking abstinence (113). 
Any missed sessions were made up at another time.
After four weeks of the exercise program, subjects were asked to quit smoking 
completely. To assist participants, nicotine replacement therapy (NICODERM ®) was 
given to each participant. These daily patches were placed on the skin. Doses depended 
on each individual’s level of smoking, but followed the recommended guidelines based 
on the Nicoderm®, 3 step, 10 week program: 1) A 21mg patch each day for 6 weeks; 2)
A 14mg patch each day for 2 weeks; 3) A 7mg patch each day for 2 weeks, for a total of 
10 weeks. Smoking cessation was confirmed by weekly expired carbon monoxide tests 
which occurred at random once per week for the 10 weeks.
Upon completion of the fourteen week intervention (including the ten weeks of 
smoking cessation and nicotine replacement therapy described above), participants 
returned to the lab for follow-up testing.
4.5 Data analysis
HR, SBP, DBP, Q, SV, and MAP were averaged over the five minute resting period at 
the start of each protocol. Pressure waveforms, Q, and SV were calculated from the 
modelflow method on a beat-by-beat basis from the BP waveform (200). TPR was 
calculated from the MAP divided by Q.
4.5.1 Vascular Mechanics
4.5.1.1 Pulse Wave Velocity
Pulse wave transit time was measured as the time from the upstroke of velocity from 
the carotid velocity measured from Doppler ultrasound to the diastolic foot of pressure 
measured at the finger (Finometer) or the foot of pressure measured at the toe (pulse
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oximeter). PWV was measured using the distance from the heart to finger or toe, divided 
by the pulse wave transit time to the finger or toe.
4.5.1.2 Local Conduit Vessels
Arterial diameters were made from 2D B-mode images taken in the long-axis plane. 
Diameter measurements were made at end-systole and end-diastole. Three measurements 
were taken: 1) From outer edge of the anterior wall to inside the posterior wall (including 
the intima-media); 2) From the inner edge of the anterior wall to inside the posterior wall 
(including the intima-media); 3) From the outside of the intima-media of the anterior wall 
to inside the posterior wall (including the intima-media) (Figure 4.1). This was repeated 
three times across (right, middle and left side) the entire imaged vessel. The three values 
were then averaged to determine: Wall thickness = (2-1); Intima-Media Thickness = (3- 
2); and Diameter = (2). The equations for Distensibility, Compliance, Peterson’s Elastic 
Modulus, Strain, and Arterial Stiffness are given in Section 2.5.1.1 Table 2.1.
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Figure 4.1 Carotid Artery Image taken in B-mode using ultrasound imaging. 1. From 
outer edge of anterior wall to inside the posterior wall (including the intima-media); 2. 
From the inner edge of the anterior wall to inside the posterior wall (including the intima- 
media); 3. From the outside of the intima-media of the anterior wall to inside the posterior 
wall (including the intima-media).
4.5.1.3 Peripheral Forearm Vascular Mechanics
Blood flow was calculated as the product of diastolic artery cross-sectional area and
the instantaneously recorded blood velocity. Cross-sectional area was calculated using the 
end-diastole diameter obtained from the average of three measurements of vessel 
diameter from the ultrasound 2D B-mode image.
Peripheral R, C, K, and L values were determined using the lumped Windkessel 
model (and discussed in Section 2.5.3) (211). The value of vascular R was determined 
from simultaneous measurements of mean pressure (Finometer) and mean flow (Doppler 
Ultrasound) at the point of entry to the forearm vascular bed. In the same way, the values 
of C, K, and L in a vascular bed can be determined from simultaneous measurements of 
the oscillatory components of pressure and flow at the point of entry. The calculations of 
C, K, and L are based on a modified Windkessel model, where C, K, and L, arearranged 
in series and are in parallel to R. After determining R, this value is entered into the
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impedance formula (Section 2.5.3 Equation 1), whereby C, K, and L are estimated until a 
calculated waveform is congruent to the measured waveform.
Ten congruent, similar waveforms of ECG, brachial pressure, and brachial flow were 
obtained from each subject. These data were saved in MATLAB format to be entered into 
the RCKL program. Due to the unknown shift during calculation of brachial pressure 
from the finger, several datasets are saved with different shifts. The correct shift was 
determined by the estimated waveform that gave the lowest error, calculated as the square 
of the difference between the estimated and measured waveforms at each point along the 
curve. The values of C, K, and L that give the lowest error, were deemed the ‘best’ fit. It 
is important to note that an exact fit cannot be determined as the model is a simplified 
representation of the vascular system.
4.5.2 Arm Volume
Arm volume was measured to address the potential impact of arm size on the 
measured variables. This value was calculated from measurements of arm length (wrist to 
elbow) and arm circumference taken at the wrist and elbow, assuming a conical shape to 
the arm, and using the equation:
[Length * ((wrist2 + (wrist*arm) + (arm2))]/(12/3.14)
4.6 Statistical Analysis
To address the effect of smoking compared to non-smoking control subjects, data 
were analyzed using a Mann-Whitney non parametric test (SPSS Statistics 18). The effect 
of the intervention program was assessed using a paired t-test (SPSS Statistics 18). Post- 
hoc Mann-Whitney analysis was performed to compare post-intervention subjects to non­
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smokers (control). To address interactions of age and menstrual cycle, post-hoc 
ANCOVA analysis was performed. Shapiro-Wilk tests were performed to determine if 
the data were normally distributed (SPSS Statistics 18).With all analyses, the probability 
level was p<0.05. Data are expressed as means ± standard deviation.
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CHAPTER 5 : RESULTS
BASELINE RESULTS -  NON-SMOKERS (Controls) and SMOKERS
5.1 Systemic Haemodynamics
Although within a normal, heathy range, SBP, DBP, and MAP were higher in the 
smokers compared to non-smokers (p<0.05) (Table 5.1).
Table 5.1 Subject Characteristics
Non-Smokers Smokers
N 25 53
Age (years) 25.8 ±5.3 27.7 ±5.6
Height (cm) 167.4 ±6.4 164.4 ±6.7
Weight (kg) 63.2 ± 12.0 70.2 ± 15.8
SBP (mmHg) 108 ±7 117 ± 9*
DBP (mmHg) 63 ± 6 •— 67 ± 8*
PP (mmHg) 45 ±7 49 ±9
MAP (mmHg) 78 ±6 84 ± 7*
HR (bpm) 69 ± 12 75 ± 10
Q (L/min) 5.3 ± 1.4 5.9 ± 1.4
TPR (mmHg/L/min) 17 ± 5 15 ± 4
Values are mean ± standard deviation (SD). SBP, systolic blood pressure; DSP, diastolic blood 
pressure; PP, pulse pressure; MAP, mean arterial pressure; HR, heart rate; Q, cardiac output; 
TPR, total peripheral resistance.
* Indicates p<0.05 for Smokers vs. Non-smokers.
5.2 Central Vascular Mechanics
5.2.1 Pulse Wave Velocity
PW V to the finger was not different between smokers (1363.02 ± 204.13 cm/s) and 
non-smokers (1428.82 ± 198.75 cm/s) (p=0.227). PWV to the toe was not different 
between smokers (950.91 ± 170.90 cm/s) and non-smokers (956.36 ± 143.69 
cm/s)(p=0.829).
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5.2.2 Carotid Artery Characteristics
Carotid wall thickness was not different between smokers (0.60 ±0.12 mm) and non- 
smokers (0.65 ±0.14 mm) (p=0.122). Carotid IMT was not different between smokers 
(0.42 ± 0.09 mm) and non-smokers (0.41 ± 0.08 mm) (p=0.352).
5.2.3 Local Carotid Mechanics
Local carotid measures of arterial stiffness and vascular characteristics are presented 
in Table 5.2. No significant differences occurred between groups.










Non- 0.09 ± 6.56 ± 548.64 ± 1.97 x 10'3 ± 1.23 x 1O"2 ±
Smokers 0.02 2.10 180.14 0.55 x 10‘3 — 0.36 x 1 O'2
Smokers 0.10± 6.41 ± 568.31 ± 1.99 x 10'3 ± 1.21 x 10‘2±
0.03 2.61 209.54 0.74 x 10'3 0.43 x IO'2
Values are mean ± standard deviation (SD).
5.3 Peripheral Vascular Mechanics
5.3.1 Brachial Artery Characteristics
Brachial wall thickness was not different between smokers (0.36 ± 0.07 mm) and 
non-smokers (0.38 ±0.16 mm) (p=0.195).
5.3.2 Local Brachial Mechanics
Local brachial measures of arterial stiffness and vascular characteristics are presented 
in Table 5.3. Compared to non-smokers, Arterial stiffness and Peterson’s Elastic 
Modulus were higher in smokers (p<0.05), whereas Distensibility and Compliance were 
lower in smokers (p<0.05). Compliance normalized to arm volume was also lower in 
smokers compared to non-smokers (p<0.05).
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8.86 x 10^ ± 
4.06 x 10^
2.85 x 10'3 ± 
1.34 x 1 O'3
3.92 x 10'7 ± 
2.02 x 1 O'7






6.41 x lO ^ i 
3.59 x 10"4 *
2.18 x 1 O’3 ± 
1.27 x 10'3 *
2.84 x 10'7 ± 
1.58 x 1 O'7*
Values are mean ± standard deviation (SD).
*Significant difference, p<0.05 for Smokers vs. Non-smokers
5.3.3 Peripheral Forearm vascular properties
Brachial MAP was increased in smokers (91 ± 11 mmHg) compared to non-smokers
(77 ± 8 mmHg) (pO.OOl). Brachial blood flow was similar in smokers (20 ± 11 mL/min) 
and non-smokers (24 ± 10 mL/min) (p=0.122). Forearm vascular R was increased in 
smokers (5.73 ±3.12 mmHg/mL/min) compared to non-smokers (3.99 ± 2.39 
mmHg/mL/min) (pO.Ol) (Figure 5.1). Compared to non-smokers (7.27 x 10'3 ± 3.19 x 
10'3 mL/min), forearm vascular C was decreased in smokers (4.11 x 10’3 ± 1.84 x 10'3 
mL/min) (pO.OOl). After normalizing forearm vascular C to arm volume, C was still 
lower in smokers (5.17 x 10'6 ± 2.54 x 1 O'6 mL/min/cm3) compared to non-smokers (9.87 
x 10'6 ± 4.22 x 1 O'6mL/min/cm3) (pO.OOl). Forearm vascular K was increased in 
smokers (0.20 ± 0.09 mmHg/mL/min) compared to non-smokers (0.11 ± 0.05 
mmHg/mL/min) (pO.OOl). Forearm vascular L was increased in smokers (3.34 x 10'5 ± 
4.21 x 10'5 mmHg/mL/min2) compared to non-smokers (1.39 x 10‘5 ± 1.71 x 10'5 


















Figure 5.1 - Forearm vascular mean arterial pressure, flow, and resistance in non- 





























Figure 5.2 Forearm vascular compliance, viscoelasticity, and inertia in non-smokers 
(white) and smokers (black).*Significant difference between groups p<0.05.
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LIFESTYLE INTERVENTION RESULTS -  SMOKERS (Pre) and QUITTERS 
(Post)
5.4 Subject Characteristics
Following a 14 week lifestyle intervention, twenty-two women quit smoking which 
was confirmed by self-report and an expired breath carbon monoxide reading of less than 
6 parts per million at each weekly test (88; 127). Twenty-four women were lost in the 
study and did not return for follow-up testing. Seven women returned for follow-up 
testing but did not quit smoking. Therefore the following data are presented for these 22 
women at baseline (while smoking, pre) and following 14 weeks of the intervention 
program (including 10 weeks of smoking cessation, post).
5.5 Systemic Haemodynamics
Subject characteristics and resting haemodynamics are presented in Table 5.4. SBP 
and HR were reduced in the post compared to pre smoking cessation tests (p<0.05).
Table 5.4 Smoking Cessation Subject Characteristics
Pre Post
N 22 22
Weight (kg) 70.2 ± 15.7 75.6 ±14.6*
SBP (mmHg) 119±9 113 ± 9*
DBP (mmHg) 67 ± 9 64 ±8
PP (mmHg) 52 ± 8 48 ±7
MAP (mmHg) 84 ± 8 80 ±7
HR (bpm) 73 ± 8 68 ±4*
Q (L/min) 6.3 ± 1.3 6.7 ±1.5
TPR (mmHg/L/min) 14 ± 3 13 ±3
Values are mean ± standard deviation (SD). SBP, systolic blood pressure; DSP, diastolic blood 
pressure; PP, pulse pressure; MAP, mean arterial pressure; HR, heart rate; Q, cardiac output; 
TPR, total peripheral resistance.
* Indicates p<0.05 for Post vs. Pre smoking cessation.
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5.6 Central Vascular Mechanics
5.6.1 Systemic Vascular Stiffness -Pulse Wave Velocity
PWV to the finger was not different between pre (1426.04 ± 195.86 cm/s) and post
smoking intervention (1405 ± 213.25 cm/s) (p=0.312). PWV to the toe was not different 
between pre (966.35 ± 147.57 cm/s) and post (953.85 ± 166.89 cm/s) (p=0.752).
5.6.2 Carotid Artery Characteristics
Carotid IMT (0.42±0.09 mm) and wall thickness (0.59±0.16 mm) post intervention
were not different compared to pre intervention (IMT: 0.41 ± 0.07 mm; Wall thickness:
0.60 ±0.14 mm) (p=0.426; p=0.325).
5.6.3 Local Carotid Mechanics
Local carotid measures of arterial stiffness and vascular characteristics are presented 
in Table 5.5. No significant differences occurred between groups.
Table 5.5 Local Carotid Mechanics for individuals before (Pre) and following (post) 










Pre 0.11 ± 5.57 ±1.70 500.89 ± 2.18 X IO'3 ± 1.30 X IO'7 ±
0.03 139.86 0.72 X IO'3 0.41 X IO'2
Post 0.12 ± 5.56 ± 1.95 502.54 ± 2.16 X IO'3 ± 1.39 X IO’2 ±
0.04 189.12 0.92 X IO’3 0.36 X IO'2
Values are mean ± standard deviation (SD).
5.7 Peripheral Vascular Mechanics
5.7.1 Brachial Artery Characteristics
Brachial wall thickness was not different between pre (0.37 ± 0.08 mm) and post 
(0.37 ± 0.07 mm) intervention program (p=0.911).
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5.7.2 Local Brachial Mechanics
Local brachial measures of arterial stiffness and vascular characteristics are given in 
Table 5.6. Arterial stiffness and Peterson’s Elastic Modulus were decreased following 
smoking cessation (p<0.05). Compliance was not normalized to arm volume as the arm 
volume did not change after smoking cessation.
Table 5.6 Local Brachial Characteristics for individuals before (Pre) and following 










Pre 0.03 ± 24.77 ± 2190.47 ± 6.43 x 10^ ± 2.25 x 10'3 ±
0.02 16.72 1421.65 4.10 x 10^ 1.53 x 10'3
Post 0.04 ± 15.37 ± 1302.12 ± 8.39 x 10^ ± 2.83 x 10'3 ±
0.01 5.14* 390.73 * 2.60 x IQ-4 0.85 x 10'3
Values are mean ± standard deviation (SD).
*Significant difference, p<0.05 for Post vs. Pre smoking cessation
5.7.3 Peripheral Forearm vascular properties
Forearm vascular R was decreased in post (4.33 ± 1.37 mmHg/mL/min) compared to
pre (5.88 ± 2.45 mmHg/mL/min) (p<0.01) (Figure 5.3). Brachial MAP was decreased in 
post (82 ± 9 mmHg) compared to pre intervention (91 ± 11 mmHg) (p<0.001) (Figure 
5.4). Brachial blood flow was (21.01 ± 6.93 mL/min) in quitters and similar in smokers 
pre intervention (19.02 ± 9.12 mL/min) (p=0.296) (Figure 5.5). Forearm vascular C was 
increased in post (4.96 x 10'3 ± 1.99 x 10'3 mL/min) compared to pre (3.87 x 10'3 ± 1.96 x 
10'3 mL/min) (p<0.05) (Figure 5.6). Forearm vascular K remained unchanged in pre and 
post intervention tests (0.21 ±0.10 mmHg/mL/min; 0.20 ± 0.07 mmHg/mL/min) 
(p=0.522) (Figure 5.7). Forearm vascular L was decreased in post (9.81 x 10'6 ± 9.56 x 
10'6 mmHg/mL/min2) compared to pre intervention (3.78 x 10'5 ± 4.50 x 10'5 
mmHg/mL/min2) (p<0.05) (Figure 5.8).
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Figure 5.3 Forearm vascular resistance. Individual data (Top) and Group Mean Data 
(Bottom). In both graphs, Smokers, Pre lifestyle intervention are on the left (Black) and 




Figure 5.4 Forearm mean arterial pressure. Individual data (Top) and Group Mean 
Data (Bottom). In both graphs, Smokers, Pre lifestyle intervention are on the left (Black) 
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Figure 5.5 Forearm blood flow. Individual data (Top) and Group Mean Data (Bottom). 
In both graphs, Smokers, Pre lifestyle intervention are on the left (Black) and Quitters, 
Post Lifestyle intervention are on the right (gray). No significant difference between 
groups.
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Figure 5.6 Forearm vascular compliance. Individual data (Top) and Group Mean Data 
(bottom). In all graphs, Smokers, Pre lifestyle intervention are on the left (Black) and 
Quitters, Post Lifestyle intervention are on the right (gray). *Significant difference 
between groups p<0.05.
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Figure 5.7 Forearm vascular viscoelasticity. Individual data (Top) and Group Mean 
Data (Bottom). In both graphs, Smokers, Pre lifestyle intervention are on the left (Black) 
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Figure 5.8 Forearm vascular inertia. Individual data (Top) and Group Mean Data 
(Bottom). In both graphs, Smokers, Pre lifestyle intervention are on the left (Black) and 





Seven participants who did not quit smoking but returned for follow-up testing were 
analyzed to address repeatability of the measurements on two different testing days. All 
variables (Local Carotid Characteristics, PWV, Local Brachial Characteristics, R, C, K, 
and L) remained the same between the two testing days (smokers baseline and 14 weeks 
later with no smoking cessation) (Table 5.7).
Table 5.7 Forearm RCKL Parameters for individuals who did not quit smoking at 
baseline (Smokers) and at follow-up (14 weeks).
Smokers 14 weeks
R (mmHg/mL/min) 4.51 ±1.84 4.42 ± 1.02
MAP (mmHg) 90.85 ± 14.70 83.00 ± 17.23
Mean Flow (mL/min) 23.91 ± 12.33 — 18.89 ± 1.61
C (mL/min) 3.76 x 10'3 ± 2.03 x 10'3 5.96 x 10'3± 4.18 x 10’3
K (mmHg/mL/min) 0.18 ±0.01 0.21 ±0.05
L (mmHg/mL/min2) 2.09 x 10'5± 1.52 x 10'5 8.61 x 10'6± 1.52 x 10‘5
Values are mean ± standard deviation (SD). R, forearm resistance; MAP, mean arterial pressure; 
C, forearm compliance; K, forearm viscoelastcity; L, forearm inertia.
No Significant difference between groups
5.8.2 Regression/ANCOVA Analysis
The quantity of cigarettes smoked over the lifespan was estimated for each individual 
in the smoking group. A regression analysis was performed to determine whether the 
quantity of cigarette exposure could address the variability in the results. Overall, no 
significant relationship occurred in any central vascular measure (Figure 5.9, 5.10) nor 
peripheral vascular measure (Figure 5.11, 5.12).
Groups were age-matched prior to data collection and an analysis of covariance 
verified that age did not influence the differences that were observed (p>0.05). In addition 
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Figure 5.9 Regression Analysis of Smoking Quantity vs. Central Mechanics. A. Puise 
Wave Velocity to the Finger (black) and toe (white); B. Carotid IMT; C. Carotid Wall 
Thickness; D. Carotid Strain; All variables are plotted against the estimated total number 
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Figure 5.10 Regression Analysis of Smoking Quantity vs. Central Mechanics. A.
Carotid Arterial Stiffness; B. Carotid Peterson’s Elastic Modulus; C. Carotid 
Distensibility; D. Carotid Compliance. All variables are plotted against the estimated total 
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Figure 5.11 Regression Analysis of Smoking Quantity vs. Peripheral Local 
Mechanics. A. Brachial Arterial Stiffness; B. Brachial Elastic Modulus; C. Brachial 
Distensibility; D. Brachial Compliance. All variables are plotted against the estimated 
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Figure 5.12 Regression Analysis of Smoking Quantity vs. Peripheral Mechanics.
Determined from the RCKL Model. A. Resistance; B. Compliance; C. Viscoelasticity; D. 
Inertia. All variables are plotted against the estimated total number of cigarettes smoked 
during the subject’s lifespan. No relationship occurred for any parameter.
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The main findings of this study were that 1) central vascular mechanics of carotid-to- 
finger PWV, carotid-to-toe PWV, or local carotid artery stiffness indices were not 
different between smokers and non smokers. 2) Brachial artery behaviour was altered in 
smokers with the indices of Peterson’s Elastic Modulus, Arterial Stiffness, Compliance, 
and Distensibility all indicating a stiffer local conduit artery. 3) A large range of 
peripheral bed vascular mechanics were altered in smokers with R, K, and L being higher, 
and C lower in smokers compared to non-smokers. These three main findings supported 
the first hypothesis. 4) Following a smoking cessation and aerobic exercise intervention, 
some peripheral vascular mechanics were improved whereby local brachial artery 
Peterson’s Elastic Modulus and Arterial Stiffness were reduced. Peripheral vascular bed 
mechanics were also improved as R and L were reduced and C was increased following 
the lifestyle intervention. However, K remained elevated. These results supported the 
second hypothesis with the caveat that viscoelastic abnormalities in young smokers are 
more persistent. To our knowledge, this is the first study to a) detect early markers of 
vascular dysregulation in young smokers, and b) to demonstrate improvements in 
vascular mechanics in a little as 14 weeks following a lifestyle intervention.
6.1 Hemodynamic Variables
All participants in this study were deemed healthy and did not exhibit any signs of 
cardiovascular disease or hypertension. HR, PP, TPR, Q, and SV were the same between 
both groups. Although within the clinically safe definition, SBP, DBP, and MAP were 
elevated in the smokers compared with non-smoker controls. The latter observations are 
supported by other studies that also demonstrate increased BP in smokers (95; 97; 112). 
Also, the BP was reduced in the smoking cessation group to values that were similar to
CHAPTER 6 : DISCUSSION
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the non-smoking control group. These results suggest that the smoking behaviour initiated 
an increased BP in smokers compared to non-smokers. The mechanism of the increased 
systemic BPs in smokers is not certain but the decreased compliance of the peripheral 
vascular bed in smokers (Discussed in Section 6.2.3), may contribute due to the increased 
wave speed of the reflected wave causing the forward and reflected wave to augment SBP 
(93; 109). However, PP, which reflects the dynamic components of the arterial 
vasculature, was not different between the two groups encouraging care be taken in 
ascribing a central impact of peripheral vascular stiffening.
6.2 Central Vascular Mechanics
In the current study, central vascular mechanics were assessed first by PWV across 
the entire vascular bed. This approach likely produces a weighted average of PWV 
across the various vascular segments consisting of the highly elastic aorta to the muscular 
femoral artery, to the microvessels. Systemic measurement of arterial stiffness, as 
indicated by PWV, was not different between smokers and non-smokers. This is 
supported by numerous studies who also found no difference in PWV in smokers (95; 97; 
112; 156). However, other studies have demonstrated an increase in PWV in smokers (87; 
190; 204). The reasons for the discrepancy remain obscure. However, one factor may be 
the timing of the measures within the smoking behaviour. For example, consistency in 
PWV change is reported in studies investigating the effect of smoking one cigarette. 
Acutely, smoking causes increased PWV and systemic stiffening (54; 95; 97; 98; 204). 
Also, the chronic increase in PWV may result from greater smoking years and age-related
changes (87; 204).
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Second, discrete measurements of carotid artery vascular stiffness were included as 
markers of local central artery changes to represent characteristics of central elastic 
arteries in the absence of other segments. Alterations in these features of the carotid artery 
are highly correlated to the presence and likelihood of developing severe atherosclerosis 
or vascular disease (178; 203). However, as with systemic PWV, no differences were 
observed between smokers and non-smokers in any measure of carotid artery vascular 
mechanics.
Our values of carotid artery mechanics are consistent with normative data of healthy 
young subjects as reported in a review of current literature by O’Rourke e t a l. (2002) 
(145). Importantly, the current results support previous findings in young smokers where 
no change in large artery compliance or distensibility was found (195). In addition, 
smokers in the current study exhibited no increase in IMT and, therefore, showed no signs 
of atherosclerotic plaque in the carotid artery.
Other studies investigating the effects of smoking in older individuals have found 
increased local stiffness (87) and IMT (9; 13; 150) suggesting that smokers will exhibit 
alterations in central arteries. The discrepancy in findings may be accounted for by the 
age of the participants. In the majority of studies the age range is wide and the average 
age is greater than 40 years of age (9; 10; 87). The observed differences between the 
current and previous reports may also be accounted for by the age of the participants who 
may have been smoking for a greater number of years (191). Thus, central vascular 
alterations may occur later in life due to the progression of vascular disease from the 
peripheral to central arteries. This progression may be accelerated once an individual
reaches a certain age and presents other confounding factors such as high BP, high 
cholesterol, and obesity (94; 205).
6.3 Peripheral Vascular Mechanics
To our knowledge, this study is the first to describe peripheral vascular mechanics in 
young smokers. This new evidence was due to the inclusion of local brachial artery and 
forearm vascular bed mechanics in the analysis, both of which point to a stiffer and 
remodelled forearm vascular bed.
The peripheral muscular brachial artery demonstrated alterations of local vascular 
mechanics. Arterial stiffness was increased in smokers and was demonstrated by elevated 
Peterson’s Elastic Modulus and decreased compliance and distensibility of the brachial 
artery. The elevation in Peterson’s Elastic Modulus demonstrates the increased pressure 
required to inflate the artery. A reduced compliance and distensibility represents a 
decreased distension for a given pressure. Despite these results, the majority of studies 
have not found any changes in muscular artery stiffness (97; 195). However, as outlined 
above, the age ranges of these previous studies were different and these studies grouped 
male and females together. Various studies have demonstrated large differences between 
males and female subjects (31; 58) and therefore grouping both sexes together may wash 
out any differences in smokers. The current analysis studied exclusively the vascular 
properties of female smokers, providing a more homogeneous population but also 
forming a distinct delineation for interpreting the results.
Incorporating a Windkessel modelling approach for the forearm vascular bed 
identified peripheral bed vascular mechanics and was able to detect changes in smokers 
compared to non-smokers. This is a lumped model in that it incorporates all levels of the
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vascular bed below the point of measurement. Thus, there is a proportionately larger 
element of microvascular contribution to these data than any other method of studying 
vascular health noninvasively in humans. McVeigh e t a l. (1997) were the first to observe 
altered peripheral vascular mechanics in smokers in the absence of changes to central 
vascular properties (122). The decrease in peripheral compliance observed was identified 
by pulse contour analysis and therefore may pose some limitations (122).
Our results also demonstrate altered peripheral vascular mechanics as R was elevated 
in smokers due to an increased MAP. R reflects the steady state of blood flow and the 
pressure that the heart must generate to deliver adequate blood to the periphery. This 
increased R in smokers will increase the load on the heart and may result in left 
ventricular remodelling over time (93; 109). Increased R, controlled by the diameter of 
the downstream vasculature, identified a more constricted system in smokers which may 
be due to increased sympathetic activity (24; 135; 198) and/or decreased dilatory 
compounds such as nitric oxide (147; 152) and sex hormones (19; 75; 123) in smokers.
The dynamic parameters regulating oscillatory blood flow, namely C, K, and L, were 
also altered in smokers. Decreased C and increased K demonstrate the reduced capability 
of the vessel wall to stretch and store blood volume during systole so that the vascular 
recoil can contribute to continuous blood flow during diastole. L, the energy required to 
accelerate the blood from the heart, was also elevated in the young smokers.
In support of our findings, Messerli (126) observed a greater increase in arterial 
stiffness compared to the increase in BP. Although this study was conducted in 
hypertensive patients, it was suggested that the increased stiffness was also due to
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structural remodelling. Avolio e t al. (1998) linked the structural remodelling and 
stiffening to the load bearing properties of collagen, which may also relate to the 
resistance to stretch of the vessel wall, and contribute to increased K and decreased C 
(11). The degradation of elastin may also contribute to the decreased compliance (41; 
207).
However, the C and K of the vessel wall are not regulated by structural components 
alone. In diseased vessels, the myogenic response may be altered as increased cross- 
linking between actin and myosin and increased calcium levels may increase the 
contraction response to stretch (11; 41). This may decrease the compliance and increase 
the viscoelasticity of the vessel wall. The inability to dilate is also impaired in both 
smokers and in a diseased vessel, as the reduction in endothelial function (104; 121; 204; 
213) may reduce nitric oxide and other vasodilatory molecule formation and contribute to 
decreased arterial compliance. In addition, increased sympathetic activity (24; 135; 198) 
and decreased estrogen (19; 75; 123) and signalling molecules (147; 152) observed in 
smokers are other mechanisms that may increase the resistance and visoelasticity and 
decrease the compliance of the vessel wall. Although these were not measured in this 
study, they may provide mechanisms that alter the parameters controlling blood flow.
In the current study we have demonstrated the limitation of focusing solely on central 
artery changes when searching for early markers of vascular maladaptations. Central 
vascular mechanics and/or systemic stiffness are the major outcome variables for the 
majority of clinical and research studies investigating risk factors and the progression of 
vascular disease. The findings of this study demonstrate the importance of studying 
peripheral vascular bed mechanics.
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6.4 Effect of a Lifestyle Intervention on Peripheral Vascular Mechanics
Following a lifestyle intervention of aerobic exercise and smoking cessation,
peripheral vascular mechanics were improved. While local brachial artery compliance 
and distensibility were not improved, local Peterson’s Elastic Modulus and Arterial 
stiffness were decreased following the lifestyle interventions. Furthermore, forearm 
vascular bed mechanics also demonstrated improvements following the lifestyle 
intervention. Specifically, R was decreased and returned the quitters to similar levels as 
non-smokers. Importantly, this reduction in R appeared to be due to a decreased MAP as 
forearm blood flow remained constant. However, the change in R suggests an overall 
dilation of the forearm vascular bed related perhaps to a myogenic mechanism. Although 
forearm C was improved post intervention, C was still decreased compared to non- 
smokers. This suggests that C is a malleable feature of the forearm and that, perhaps, 
additional time is required for full restoration of this variable. The improvement in C 
supports previous studies that observed an increase in arterial compliance following 
aerobic exercise (61; 185) and a decreased PWV following smoking cessation (87) and 
thus decreased stiffness. In contrast, forearm K remained unchanged between the pre and 
post intervention measurements and persistently higher compared to non-smokers. Thus, 
the viscoelasticity of the forearm bed demonstrates resistance to change, relative to the 
other mechanical properties. Importantly, this differential response suggests that K can 
be independent from C or L, as suggested earlier (210-212). Similarly, vascular bed L 
was improved following the intervention and was lowered similar to non-smokers. 
Vascular bed L is probably one of the least understood parameters regulating blood flow. 
However, the improvement of forearm L represents an improved matching of blood flow
and pressure. The lower the inertia, the decreased time it will take the flow to reach 
steady state (36; 210).
This study is the first to our knowledge to demonstrate improvements in peripheral 
vascular mechanics in as little as 14 weeks following aerobic exercise and smoking 
cessation. However, the incomplete recovery of these properties points to the need for 
longer-term interventions to determine whether complete reversal can be achieved.
It may be of interest to determine whether the differential impact of lifestyle 
modification on peripheral versus central vascular properties are specific to smokers or if 
this is a general pattern of vascular dysregulation. In this context, the current findings are 
in agreement with the study by Aizawa e t a l. (2009) who found that an eight week 
aerobic exercise program significantly increased brachial arterial compliance but not 
central arterial compliance in older adults with metabolic syndrome (3). This earlier study 
was not able to assess the forearm vascular bed. Nonetheless, the sustained increase in K 
and lower C post intervention in smokers of the current study, compared to non-smokers, 
may allude to the persistence of smoking-induced alterations. Increased collagen, smooth 
muscle cell proliferation, and decreased elastin may contribute to these altered 
parameters. The purpose of this study was not to determine the mechanisms for 
alterations in these parameters, but the pathophysiology regulating these parameters will 
be important to study in the future.
The improvement in compliance may also play a role in the reduced MAP which then 
decreased R. An improved C in the peripheral bed should decrease the wave speed of the 
reflected wave and may decrease the augmentation of systolic pressure seen pre
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intervention in smokers (137). Arterial compliance is represented as the slope at a 
specific point on the pressure-volume curve (102). The pressure-volume curve would 
indicate that the artery is more compliant at low BP and less compliant at high BP. In the 
current study, both SBP and DBP were significantly reduced following the intervention, 
causing a leftward shift in the pressure-volume curve. It is possible that this reduction in 
BP contributed to the observed improvement of peripheral arterial C. However, similar to 
Cameron e t a l. (1994) the increase in compliance (28%) is greater than that due to 
changes in BP (5%) and is likely to include a component due to change in intrinsic 
arterial compliance (39). Our results support the proposition that there is a primary, 
lifestyle intervention-induced, change in vascular compliance in excess of that explained 
by an associated fall in BP.
We can only speculate on the mechanism by which the intervention program 
improved peripheral vascular mechanics in the present study. Arterial compliance is 
partly determined by the intrinsic elastic properties of the artery, namely the composition 
of elastin and collagen (structural determinants) and the vasoconstrictor effect of smooth 
muscle cells (functional determinant) (137; 179). In as little as 3 months of exercise 
training, Dinenno e t a l. (2001) found that significant arterial remodelling occurs in the 
femoral artery (48). It is also possible that the increased pressure and mechanical 
distension during exercise sessions “stretched” collagen fibres and modified their cross- 
linking, thereby increasing arterial compliance (35). In addition, tension generated by the 
connective tissue is reduced in a dilated vessel (179).
Arterial compliance can be altered over a short time period, even acutely, via 
modulation of the sympathetic adrenergic tone of smooth muscle cells in the arterial wall
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(17; 33; 211). Also, a reduction of nicotine, which has been observed to increase smooth 
muscle cell proliferation (40), may also contribute to decreased stiffness and constriction 
regulated by smooth muscle cells. In this context, it is possible that regular aerobic 
exercise and smoking cessation, both which may decrease sympathetic activity (125; 129; 
132; 146; 160; 209), combined with an elevated sympathetic activity due to cigarette 
smoking pre intervention (135), reduced the chronic sympathetic activity post 
intervention. Exercise training also increases shear stress and endothelial function. 
Although smokers demonstrate reduced nitric oxide bioavailability (147), and thus 
reduced endothelial function (156; 213), the ability of smokers to dilate in response to 
exogenous vasodilatory sources is intact (121; 204) and may provide evidence for the 
short term improvements in peripheral vascular function. Following smoking cessation, 
nicotine and other compounds in cigarettes are no longer present to reduce nitric oxide 
and other vasodilatory compounds availability. In fact, following smoking cessation 
evidence suggests that nitric oxide concentration is restored compared to non-smokers 
(141). Therefore, the endothelial dysfunction in smokers may be restored as increased 
levels of vasodilatory molecules are present. Future studies will be needed to determine 
whether sympathetic activity is reduced and endothelial function restored following this 
type of combined intervention.
In summary, the results support the hypothesis that peripheral parameters can be 
improved without changes in central parameters. Since the smokers were young and 
showed no signs of cardiovascular disease, it was not expected that central vascular 
mechanics would be significantly altered compared to non-smokers. In those smokers that
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were not successful in smoking cessation, the likelihood of central vascular alterations in 
their lifespan is higher.
6.5 Correlation Analysis
To address the discrepancy from previous studies that suggest that the number of 
smoking years is (10; 51; 133; 148; 149) or is not (13; 21), correlated to cardiovascular 
risk factors, we also investigated possible correlations in peripheral and central vascular 
mechanics. Overall, this study demonstrated no association between any central or 
peripheral variable and the quantity of cigarettes smoked. Also, the vascular indices were 
not related to the participant’s age. Although not unexpected, due to support from 
previous studies, these results were surprising in that we studied both central and 
peripheral factors and demonstrated smoking induced alterations. Although our 
participants were young we still were able to include a wide range of smoking years, 
ranging from 2 to 23 years smoking. A possible explanation for the lack of correlation 
may be that the altered peripheral vascular mechanics are due to properties regulating 
blood flow that are turned ‘on or ofF with smoking. For example, cigarette smoke causes 
an increase in sympathetic activity (24; 135; 198) which may cause constriction, 
increased R, and/or decreased C. Thus, while each cigarette may acutely cause 
neurogenic vascular stiffening, the continuous smoking results in a chronic sympathetic 
activation with continuous changes in peripheral vascular stiffness. Certainly, recent 
evidence points to the stiffening impact of reflex sympathetic activation on the brachial 
artery (33; 165). Alternatively, structural remodelling in the periphery may take 
significantly less time than central remodelling, as supported by the little time required to 
improve these characteristics following our lifestyle intervention. In addition, Weil e t a l.
(2009) observed endothelial dysfunction in young smokers who had been smoking for 
less than 5 years (199). Support for these hypotheses requires future testing.
6.6 Implications
This study has clinical and public health implications. The clinical relevance of our 
findings lies in our ability to detect alterations in peripheral vascular mechanics in the 
absence of central changes in young smokers. The importance of detecting early changes 
in vascular stiffness indices is that these may reflect the early onset of vascular disease. 
Our study also demonstrated that a 14-week aerobic exercise and smoking cessation 
intervention produced a significant reduction in peripheral microvasculature arterial 
stiffness indices in young women who smoke. Therefore, this intervention reduced the 
risk level for cardiovascular pathology in these women and may prevent cardiovascular 
diseases later in life. It is important to note as well that without measures of peripheral 
vascular bed properties, the benefit of the smoking cessation program would not have 
been observed. The improvement of arterial stiffness is an important outcome for the 
primary prevention of cardiovascular disease and demonstrates the need to identify 
successful intervention strategies to implement in public health. Our study demonstrated 
that a laboratory-based intervention of smoking cessation and aerobic exercise is an 
effective means to achieve these positive results.
6.7 Limitations
The Windkessel model used to study the forearm vascular bed is a lumped model and 




We are also limited in our ability to conclude whether the aerobic exercise or smoking 
cessation intervention caused the improved peripheral vascular mechanics. Additional 
studies are required to determine the independent effects of aerobic training or smoking 
cessation in this population. However, the purpose of this study was not to evaluate 
whether one or the other could result in improvements; rather, it was to evaluate whether 
these vascular alterations could be modified at all by a comprehensive lifestyle 
intervention.
For logistical reasons of scheduling tests and training, this study did not standardize 
the phase of menstrual cycle for participants. However, in our sub-analysis we observed 
no relationship to central or peripheral vascular mechanics relative to the day of cycle. 
Therefore, the impact of smoking and the intervention in this study were not related to 
menstrual phase during testing.
Finally, carotid arterial compliance and distensibility calculations used PP values 
from the brachial artery since we could not measure BP at the carotid artery. While 
numerous studies employ the use of this technique (2; 2; 97; 195), this may have 
introduced an error in these calculations as brachial BP may overestimate carotid BP 
(137). However, in anesthetized dogs, a linear relationship was found between pressure 
in the brachial artery and pressure in the common carotid artery over a relatively wide 
range of pressures (158).
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CHAPTER 7 : CONCLUSION
The results of the present study extend the prior findings of the effects of smoking on 
central and peripheral vascular mechanics.
First, our cross sectional study allowed us to determine the effect of smoking on both 
central and peripheral vascular mechanics. To our knowledge, this is the first report of 
segmental vascular mechanics in at-risk individuals. We found that reductions in central 
artery stiffness were not present in young women smokers. However, peripheral vascular 
mechanics were altered in smokers as R, K, and L were all elevated compared to non- 
smokers. These variables have not been reported previously in this population. Further, 
vascular compliance of the brachial artery locally, and of the entire forearm vascular bed 
(C) using the windkessel model, were lower in smokers.
Second, the follow-up study demonstrated that a 14 week lifestyle program of 
aerobic exercise and smoking cessation can improve peripheral vascular compliance in 
women who smoked previously. Moreover, this allowed us to examine the parameters 
regulating blood flow in the periphery identified as R, C, K, and L. These results suggest 
that a relatively short intervention of aerobic exercise and smoking cessation in healthy 
young women smokers can restore some of the dynamic arterial parameters regulating 
blood flow. However, the sustained increase in K demonstrates the persistence of this 
effect of smoking.
Our results have a number of potentially important clinical implications. Reductions 
in arterial compliance are believed to contribute significantly to the pathophysiology of 
vascular and cardiac diseases as cardiac function is affected by increasing the aortic
impedance to ejection of left ventricular SV (109). This, in turn, may contribute to 
reductions in left ventricular performance. In addition, vascular stiffening precedes 
atherosclerotic plaque build-up, increasing the likelihood of a heart attack or stroke (6). In 
this study, there was no difference in central vascular stiffness between young smokers 
and non-smokers suggesting that the vascular changes that are observed with smoking 
develop first in the periphery and move centrally. Thus, the decreased peripheral arterial 
C, increased R, K, and L may provide the first evidence of earlier vascular disease 
markers in young smokers. Our results also demonstrate that despite the negative 
alterations in peripheral vascular mechanics in young smokers, some of these parameters 
can be improved in as little as 14 weeks of a lifestyle intervention. The early detection of 
vascular disease may significantly impact intervention strategies and decrease one’s 
increased risk of developing vascular disease. Delineation of the mechanisms to explain 
these findings was not the purpose of this study and remain to be elucidated.
In perspective, this study illustrates the importance of assessing vascular mechanics 
in the peripheral vascular bed as well as central arteries. Stated differently, measuring 
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